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ABSTRACT 
PERCEIVED RECURRENCE RISK AND HEALTH BEHAVIOR CHANGE AMONG 
BREAST CANCER SURVIVORS 
MAY 2013 
EMILY J KONIECZNY, B.S., JAMES MADSION UNIVERSITY 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Katherine W. Reeves 
Over one third of breast cancer survivors report “fear of recurrence” as the primary concern 
after diagnosis and treatment. Behavior changes such as exercise and weight loss post cancer may 
reduce recurrence risk. How perceived recurrence risk affects behavior change is unknown. We 
evaluated this association in the Breast Cancer Survivorship Study, a cross-sectional study of 301 
breast cancer survivors. Data on perceived recurrence risk (local and distant) and health behavior 
change (alcohol, exercise, nutrition, smoking, sun exposure, supplement use, weight) were 
assessed by mailed questionnaire. Multivariable logistic regressions were used to evaluate 
associations between perceived recurrence risk and health behavior change, and multinomial 
logistic regression to assess direction of change. 47.6% of women perceived their local recurrence 
risk <10%, while 36.3% perceived distant between 10-30%. Participants mean age was 60 years 
and had predominantly early stage cancer. Over 90% of women reported making a behavior 
change. Significant associations were found between higher perceived recurrence risk and 
behavior changes of nutrition (OR 3.1, 95% CI 1.6-6.3) and sun exposure (OR 2.5, 95% CI 1.2-
5.0). Exploratory direction of change analyses found women with higher perceived recurrence 
risk were more likely to make positive changes in nutrition (OR 4.0, 95% CI 1.9-8.2) and sun 
exposure (OR 2.5, 95% CI 1.2-5.2). Overall, we found trends that women are likely to make 
specific behavior changes as their perceived recurrence risk increases. Findings provide a 
baseline for future research to identify survivors more likely to make behavior changes that affect 
their long term health.    
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CHAPTER 1 
INTRODUCTION 
 
There are more than 2.9 million breast cancer survivors in the United States (1). Survival 
rates have been steadily increasing due to improvements in both treatment and early detection, 
with 5 year survival for localized disease of 98.6% across all races (2).  Women diagnosed with 
stage 0-III breast cancer treated with surgery plus adjuvant or neoadjuvant therapy have a local 
recurrence risk of 6-13% (3-6). Whereas, women treated with breast conserving therapy have a 
distant recurrence risk of approximately 24% (7). In fact, one study shows that 39% of breast 
cancer survivors name “fear of recurrence” as their primary concern (8). Additionally, 45% of 
women reported their local recurrence risk of invasive breast cancer to be likely, and 39% of 
women reported their distant recurrence risk to be likely (9). Breast cancer survivors are also at 
an increased risk for developing secondary tumors, cardiovascular disease, osteoporosis, and 
diabetes (10) . 
 Making lifestyle behavior changes post cancer diagnosis and treatment may reduce the 
likelihood of these outcomes. In particular, behavior changes such as maintaining a healthy 
weight (11), being physically active (11), increasing fruit and vegetable consumption (11) and 
controlling alcohol intake (12) post cancer diagnosis and treatment has been linked to a reduction 
in breast cancer recurrence risk. Lifestyle behaviors after cancer diagnosis and treatment have 
been associated with breast cancer recurrence and survival rates; however the direction of effect 
remains controversial. Higher body mass index, increased total fat intake, and increased alcohol 
consumption have been reported to increase recurrence risk (13, 14). In contrast, increased fiber 
intake and exercise, increased soy, and increased fruit and vegetable consumption (13-15)  have 
been reported to either decrease recurrence risk or to have no impact.  
 The American Cancer Society recommends breast cancer patients focus on maintaining a 
healthy weight through physical activity and a diet high in fruits and vegetables and low in 
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saturated fat (2). One study of cancer survivors reported 86% of cancer survivors make at least 
one behavior change following diagnosis (16).  Among them, 75% reported at least one positive 
behavior change and 38.5% reported making a negative change post diagnosis (16). Other 
survivorship literature has cited approximately 40-50% of cancer survivors report positive 
changes in their diet (17), 15-26% report increased physical activity (6, 16), 51% reduced fat 
intake and 44% increased fiber intake since diagnosis (10). Other common changes include 
regular health checkups, taking vitamins and/or supplements, and increasing sun protective 
behaviors (18). Literature has also found 9.6% of adults continued to smoke after a cancer 
diagnosis and 30.1% exercised less (10). Positive behavior change is associated with younger age, 
higher education, longer time since diagnosis, more comorbidities, increased vitality, fear of 
recurrence, and spiritual well-being. Negative behavior change has been associated with younger 
age, being non- Hispanic African American, being widowed, divorced or separated, and 
decreased physical and emotional health (18). Overall, one study has shown that 14% of cancer 
survivors made no health behavior changes after cancer diagnosis (16). 
Perceived severity of disease or fear of recurrence is often a catalyst for health behavior 
change among breast cancer survivors (6, 18, 19). Psychosocial theories such as the Social 
Cognitive Theory (20), Parallel Processing Model (21), Behavior Motivation Hypothesis (22), 
and other cognitive (23) and emotional constructs (24) have all been cited as possible 
explanations as to why risk perceptions play an important role in behavior change.  
 Only two studies have assessed the relationship between perceived recurrence risk and 
health behavior change in breast cancer survivors (6, 19). Burris et. al found that women with a 
higher perceived recurrence risk were less likely to limit their food intake to maintain or lose 
weight (r=-0.16, p-value <0.05) compared to women who perceived themselves to have a lower 
recurrence risk, but overall, risk perception was largely unrelated to behavior (6). O’Neill 
similarly found that recurrence risk perception was unrelated to behavior change (BMI- OR 1.00, 
95% CI: 0.98-1.01; fruit and vegetable consumption- OR 0.99, 95% CI: 0.97-1.01; and physical 
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activity- OR 1.00, 95% CI: 0.99-1.02) (19). Current literature has only focused on perceived local 
recurrence risk and has limited control for covariates, warranting further research.  
 Given the importance of behavior change following breast cancer diagnosis and treatment 
in relation to risk of recurrence or development of other chronic diseases, it is important to study 
characteristics that lead to behavior change. Therefore, we investigated the relationship between 
perceived recurrence risk and health behavior change among breast cancer survivors using data 
from the Breast Cancer Survivorship Study, a cross-sectional study, based at Baystate Medical 
Center in Springfield, Massachusetts. We hypothesized that breast cancer survivors with a higher 
perceived recurrence risk would be more likely to report changes to their health behaviors.  
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CHAPTER 2 
METHODS 
 
A. Study Population 
 In 2008, the Breast Cancer Survivorship Study identified breast cancer survivors through 
the Baystate Medical Center Tumor Registry. Eligible patients were diagnosed between 1997-
2007 and subsequently treated by the principal investigators (Drs. Makari-Judson, Mertens, and 
Katz). Additional eligibility included: 1) women >18 years of age, 2) diagnosis of stage I, II, or 
III breast cancer, 3) 12 months or greater since diagnosis, and 4) no distant relapse. Eligible 
patients received a letter from their physician inviting them to participate in the study. Study 
exclusion criteria were: 1) male breast cancer, 2) non-English, non-Spanish speaking patients, and 
3) patients unable to complete the questionnaire due to dementia or disability.   
A total of 1022 eligible women were mailed a consent form and questionnaire. The first 
301 completed questionnaires returned were included in the study. The questionnaire collected 
data on sociodemographic factors, smoking, alcohol use, family history of breast cancer, personal 
breast cancer history, perceived recurrence risk, and changes in health behavior. Women were 
excluded from analysis if they did not provide information about their perceived recurrence risk 
or behavior changes (n=34), leaving a final population for analysis of 267.   
 
B. Data Collection 
Perceived recurrence risk of breast cancer was measured by a self-administered 
questionnaire. In some cases, the questionnaire was administered over the phone. Women were 
asked, “Thinking back to the day you completed your treatment, estimate your risk of having a 
breast cancer recurrence at the site of surgery”, and “Thinking back to the day you completed 
your treatment, estimate what you believed to be your risk of recurrence of cancer outside the 
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breast over 10 years from completing therapy”. Participants were asked to choose from the 
following options: 0-10%, 10-30%, 30-60%, or >60%.  
 Health behavior change also was assessed through the self-administered questionnaire. 
Participants were asked to check if they had made a change post-diagnosis or post-treatment in 
any of the following behaviors: alcohol, exercise, nutrition, smoking, sun exposure, use of 
supplements, and weight. Participants reporting a behavior change were asked to describe the 
change in a free text entry. 
 Data for covariates were gathered through self-report via the questionnaire and medical 
record abstraction. Covariates gathered by questionnaire included: age, race, socioeconomic 
status, educational level, family history of breast cancer in 1st degree relatives, alcohol 
consumption, smoking history, and years since diagnosis. Covariates collected from the medical 
record data included:  stage of breast cancer, lymph node involvement, surgical treatment, 
chemotherapy treatment, hormonal treatment, radiation treatment, estrogen receptor (ER) status, 
progesterone receptor (PR) status, and actual distant recurrence risk from the Adjuvant! Online 
calculation (25). 
 
C. Statistical Analysis 
Both local and distant perceived recurrence risk were collapsed into three categories 
(<10%, 10-30%, and >30%) due to the low number of women who perceived their recurrence risk 
to be greater than 60%.  
Each behavior change was assessed separately and classified as either “yes” or “no” in 
regards to the presence of a change. A variable denoting any behavior change was created and 
defined as making at least 1 change among any of the behaviors. Participants noting a behavior 
change and who provided information about the type of change were further classified as either 
having made a positive change or a negative change. A response was classified as a positive 
change if it met one of the following requirements: decrease in alcohol consumption, increase in 
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exercise, increased consumption of fruits and vegetables, whole grains, and fiber, or decreased 
amount consumed, decrease or cessation of smoking, spending less time in the sun or wearing 
more sun protection, began taking a multivitamin, vitamin D, calcium, vitamin E, or vitamin C, or 
decrease in body weight. A response was classified as a negative behavior change if it met one of 
the following requirements: increase in alcohol consumption; decrease in exercise; increase in red 
meat or fat consumption, eating less fruits and vegetables, whole grains, and fiber or increased 
amount consumed; increased smoking; increased sun exposure; taking supplements that did not 
include at least one of the supplements classified as positive; or an increase in body weight. 
Variables denoting any positive change or any negative change were also created and defined as 
making at least 1 positive or at least 1 negative change, respectively.  
Some participants indicated a behavior change but did not provide enough information 
for further classification. Additionally, some participants indicated fluctuations in their behaviors 
over time (e.g. loss then gain of weight); in these cases we used the initial change to classify the 
direction of change. 
 Data were analyzed using STATA 12.1. We calculated summary statistics for all 
variables and compared the distribution between levels of each of the aforementioned outcome 
variables. T-tests, chi square, or Fisher’s exact tests were used for continuous and categorical 
variables, respectively.  
 We used logistic regression to calculate adjusted odds ratios and 95% confidence 
intervals between local and distant perceived recurrence risk and health behavior change. We 
used multinomial logistic regression to investigate the direction of behavior change while 
controlling for confounders. 
Potential confounders were chosen based on knowledge of a relationship with perceived 
recurrence risk and health behavior change and are shown in Table 1. We fit a univariable logistic 
regression model for each potential covariate. Any covariate with a p-value <0.25 from the 
likelihood ratio test was fit into an initial multivariable model, and assessed via likelihood ratio 
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tests to determine whether or not a variable was needed in the model. Changes in the estimates of 
other coefficients were considered, and if it was greater than 10%, the variable was kept in the 
model. Two sided P values ≤ 0.10 were considered statistically significant.  
To assess if behavior changes varied by length of time since diagnosis, results were 
stratified on time since diagnosis. To assess concordance of recurrence risk, we compared 
women’s distant perceived recurrence risk to their Adjuvant! Online score and grouped them as 
accurate, overestimated, or underestimated. Frequencies, adjusted odds ratios, and 95% 
confidence intervals were calculated in the same manner as described above. 
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CHAPTER 3 
RESULTS 
 
The average age in this sample was 59.7 years with over 90% self-identifying as 
Caucasian (Table 1).  The majority of the women in this sample attended college, consumed 
alcohol rarely, and was never or past smokers. Nearly 60% of women who reported smoking at 
their breast cancer diagnosis made a positive change to their smoking behavior. Over 70% of the 
sample had no previous family history of breast cancer, 47% of women were diagnosed with 
stage 1 cancer, and more than 62% of women were greater than 5 years past the initial diagnosis.  
Approximately two-thirds (66.3%) of women did not have lymph node involvement, 
64.4% received a lumpectomy, 79.4% received hormonal treatment, 77.9% received radiation 
treatment, 79.8% were ER positive, and 70% were PR positive. Nearly half (47.6%) of the 
women reported their perceived local recurrence risk to be between 10% and 30%. More than half 
(53.2%) of women had Adjuvant! Online risk scores calculated between 10% and 30%, while 
only 36.3% of women perceived their distant recurrence risk to be between 10% and 30% (Table 
1). Women who were excluded from analysis due to missing information on perceived recurrence 
risk or health behaviors, were significantly older, more likely to have a lower socioeconomic 
status, to be diagnosed with Stage I breast cancer, have no lymph node involvement, not receive 
chemotherapy treatment, and more likely to perceive their local and distant recurrence risk to be 
<10% (Table 2).  
Over 90% of the population reported making a behavior change. Over 77% reported 
making at least one positive change, while 42.7% reported making at least one negative change. 
Weight was the most common change reported, with 59.2% of women reporting such a change. 
More than half of the population reported changes in exercise (54.7%), nutrition (52.4%), and 
supplement use (51.3%). Forty three percent of women reported a change in sun exposure. The 
least commonly reported changes were for the behaviors of alcohol (16.5%) and smoking 
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(12.0%). The most common positive behavior changes were reported for nutrition (43.5%), sun 
exposure (37.1%), supplement use (36.0%), and exercise (33.7%). The most common negative 
behavior change was reported for weight (33.0%). (Table 3) 
Women who made any behavior change tended to be older, have a family history of 
breast cancer, receive hormonal treatment, and were less than 5 years from their diagnosis 
compared to women who did not make any behavior change. Women who made no positive 
changes were significantly more likely to report their perceived recurrence risk to be lower as 
compared to women who made >1 positive change (Table 4).  
For most behaviors, there was a positive, though not always statistically significant, 
association between women’s perceived recurrence risk and making a behavior change (Tables 5 
& 6). We compared women with the highest perceived recurrence risk (>30%) to those with the 
lowest perceived recurrence risk (<10%). In adjusted analyses, local perceived recurrence risk 
was significantly associated with change in nutrition (OR 3.1 95% CI: 1.6-6.3) and marginally 
significantly associated with a change in sun exposure (OR 1.8 95% CI; 0.9-3.6). Distant 
perceived recurrence risk also was positively associated with a change in sun exposure (OR 2.5 
95% CI: 1.2-5.0), and marginally significantly associated with nutrition (OR 1.8 95% CI: 1.0-3.4) 
and making any negative change (OR 1.9 95% CI: 1.0-3.5).  Additionally, local perceived 
recurrence risk was positively associated with making at least one positive behavior change (OR 
3.4 95% CI: 1.3-9.4).  
We repeated the analyses with stratification by the number of years since diagnosis at the 
time of questionnaire completion (Tables 7 & 8). Nearly half (47.2%) of women were between 5 
and 10 years since diagnosis, 15.4% were greater than 10 years since diagnosis, and 37.1% of 
women were less than 5 years since diagnosis. All statistically significant results were found for 
women who reported being between 5 and 10 years since diagnosis.  
We examined perceived recurrence risk and direction of behavior change in exploratory 
analyses (Tables 9 & 10). Local perceived recurrence risk was positively associated with a 
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positive change in nutrition (OR 4.0 95% CI: 1.9, 8.2) and exercise (OR 1.9 95% CI: .9-3.9) in 
adjusted analyses. Likewise, distant perceived recurrence risk also was positively associated with 
nutrition (OR 2.0 95% CI: 1.0-3.9) and sun exposure (2.5 95% CI: 1.2-5.2) in adjusted analyses.  
Concordance of behavior change was assessed and 37% of women accurately perceived 
their recurrence risk, while 39.4% overestimated and 23.5% underestimated (Table 11). We 
compared women who overestimated and underestimated their recurrence risk to those women 
who perceived it accurately. Although not statistically significant,  women who overestimated 
their distant recurrence risk tended to be more likely to report having made behavior changes as 
compared to women who were accurate in reporting their distant recurrence risk (Table 12). 
Additionally, women who underestimated their recurrence risk, tended to be less likely to make 
behavior changes, and marginally significantly less likely to make a change in sun exposure (OR 
0.5 95% CI; 0.2-1.0) as compared to women who were accurate in reporting their recurrence risk. 
Additionally, women who overestimated their distant recurrence risk tended to be more likely to 
report positive changes to their health behaviors as compared to women who accurately perceived 
their distant recurrence risk (Table 13). 
  
11 
 
CHAPTER 4 
DISCUSSION 
 
In this study of early stage breast cancer survivors, we found that women with higher 
perceived recurrence risk were more likely to make behavior changes. Significant results were 
observed for changes in nutrition and sun exposure and indicate that higher perceived recurrence 
risk was associated with improved nutrition and reduced sun exposure. 
 Previous literature has found that perceived recurrence risk was largely unrelated to behavior 
(6, 19). Burris and colleagues observed fourteen potential recurrence risk reduction behaviors and 
found two (limit food intake to maintain current weight or lose weight and see a mental health 
professional) to be significantly associated with perceived recurrence risk. A more recent study 
published found similar results to Burris claiming adherence to healthy behavior is unrelated to 
perceived recurrence risk (19).  Variations in study results are likely due to the differences in the 
way exposure and outcome information was obtained. Burris and colleagues used Likert scale 
questions to create a 2-point composite score which gathered perceived recurrence risk 
information while O’Neill and colleagues asked women their perception on a 0-100% scale. 
Burris assessed behavior change by asking the women if they performed the behaviors in the past 
month or not, while O’Neill targeted behavioral questions to assess adherence to health behavior 
recommendations. Additionally, this topic has been sparsely studied. One study has examined this 
relationship in colorectal cancer survivors (26) and another in head, neck, and lung cancer 
survivors (27) and found that greater risk perceptions are associated with positive behavior 
changes. Our data agree with the latter studies, suggesting the presence of an association between 
perceived recurrence risk and health behavior change. 
Current survivorship literature states that maintaining a healthy BMI (11), increasing physical 
activity (11), and eating a low fat diet (28) will decrease cancer recurrence risk. Additional 
literature on the relationship of increasing fruit and vegetable intake suggests a modest benefit, if 
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any at all (11, 13-15). In our study, women were significantly more likely to make a positive 
behavior change in regards to nutrition and sun exposure. Interestingly, these behaviors have not 
been proven to reduce recurrence risk. Positive change in weight or exercise was less common 
and generally unrelated to perceived recurrence risk, despite evidence that such behavior change 
may decrease recurrence risk. Only 54.6% of the population made a change in exercise. This 
finding was surprising to us, as the clinicians treating the survivors recommend an increase in 
exercise at the diagnostic appointment. It is possible that it is easier for breast cancer survivors to 
make an adjustment to their nutrition than it is to start an exercise routine. Additionally, breast 
cancer treatment effects can include fatigue and weight gain, making a positive change to 
exercise and weight even more challenging.  
Strengths of this study include the use of a standardized questionnaire, the collection of a 
wide variety of confounders, and the use of medical record data for treatment and disease 
information. Furthermore, all of the survivors were treated within the same medical practice so 
they likely received similar medical care and advice after diagnosis and treatment. 
A limitation of this study is the assessment of the behavior change inquiry on the 
questionnaire. Women were asked to define whether or not they made a behavior change, but 
minimal quantitative information about the change was gathered. For example, a 5 pound weight 
gain was classified the same as a 50 pound weight gain. Among breast cancer survivors, it is 
common for chemotherapy to cause uncontrollable weight gain, so it is important to note that we 
could not distinguish between weight changes resulting from behavior changes from those to 
treatment regimen.  
Data on direction of behavior change were limited as some women failed to describe their 
behavior change and others did not give information useful in classifying the direction of their 
change. Further, some behaviors had a greater chance of being classified as either a positive or 
negative change. For example, in terms of nutrition, a positive behavior change was classified as 
either eating less quantity, eating a lower fat diet, eating more fruits, vegetables, or fiber, or 
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eating less red meat. Similarly, a positive behavior change for sun exposure was classified as any 
action that would reduce sun exposure such as: using more sunscreen, less exposure to the sun, or 
covering up more when in the sun. A positive behavior change for smoking, however, was either 
reducing the amount of cigarettes smoked, or quitting smoking completely. Additionally, 
associations between other behaviors may not have been seen due to small sample size and 
resulting low statistical power.  
Women in this study were told their personalized recurrence risk percentage at initial 
diagnosis by their clinician. This given risk percentage may have had an effect on the perceived 
recurrence risk they reported on the questionnaire, even though women were prompted to think 
back to the day they completed treatment when they responded. We believe this misclassification 
to occur at random and would attenuate the study results. In a separate analysis, in this sample, 
women reported their perceived recurrence risk to be consistently higher than Adjuvant! Online 
estimates (p<0.0001) (29). Adjuvant! Online is a tool used by clinicians to help determine a 
patients’ risk of an adverse cancer outcome (recurrence or mortality) by entering specific 
information about the woman such as age, tumor size, nodal involvement, histological grade, etc 
(25).    
As mentioned previously, the majority of women in this study were between five and ten 
years since diagnosis. The small size of the other groups could have led to no significant 
associations with behavior changes to be seen.  Additionally, the length of time since diagnosis 
may have caused women to report their current perceived recurrence risk rather than thinking 
back to the day treatment was completed. Reported behavior changes may also have been 
affected by the length of time since diagnosis, as women may have reported changes that have 
occurred over time, rather than as a result of their breast cancer diagnosis. This also could have 
led to misclassification and have attenuated the study results.   
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Lastly, as this was a cross-sectional study, temporality cannot be established. We cannot 
definitively state whether an increased perception of recurrence risk lead to behavior change, or if 
the reverse is true. 
 In conclusion, we found that women with higher perceived recurrence risk were more 
likely to make behavior changes, especially in improving nutrition and reducing sun exposure. 
Making drastic lifestyle changes to exercise, alcohol consumption, and smoking can be difficult 
after a breast cancer diagnosis as compared to modifying diet or sun exposure. Weight 
management and increasing exercise are the strongest predictors for lowering breast cancer 
recurrence risk, and our results present that even the women with the highest perceived 
recurrence risk could not make these behavior changes. This may be due to the fact that 
treatments for breast cancer can cause involuntary weight changes and fatigue leading to an 
increased difficulty of making positive behavior changes to weight or exercise, in conjunction 
with the general difficulty surrounding a person making positive changes to their weight and 
exercise routine. The “teachable moment” after a cancer diagnosis is vital to the transition into 
becoming a cancer survivor, and these results may help clinicians understand what motivates 
women to make health behavior changes after a breast cancer diagnosis and target them for 
interventions. Further, we discovered that women with a higher perceived recurrence risk were 
more likely to be making positive behavior changes. Findings from this study are exploratory and 
contribute to the limited literature on this topic. Future research should include gathering 
quantitative information about behavior changes and establishing temporality. 
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Table 1. Distribution of covariates according to behavior change (n=267): Breast Cancer 
Survivorship Study, 2008 (continued on next page) 
                                                         Total Any Behavior 
Change 
No Behavior 
Change 
P-Value 
              Mean SD Mean SD Mean SD 0.04 
Age (years) 59.65 9.6 59.96 9.5 55.12 9.7   
  
N % N % N %   
Race           0.32 
    Non-White 18 6.7 16 6.4 2 11.8   
    White 249 93.3 234 93.6 15 88.2   
Socioeconomic status           0.93 
   <$25,000/year 43 16.1 41 16.4 2 11.8   
   25,000-50,000/year 64 24.0 60 24.0 4 23.5   
   50,000-100,000/year 87 32.6 80 32.0 7 41.2   
   >100,000/year 58 21.7 54 21.6 4 23.5   
   Missing 15 5.6 15 6.0 0 0.0   
Educational Level            0.70 
   High School or less 87 32.6 83 33.2 4 23.5   
   College 100 37.5 93 37.2 7 41.2   
   Post Graduate 80 30.0 74 29.6 6 35.3   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
      0.09 
   None 189 70.8 173 69.2 16 94.1   
   One or more 77 28.8 76 30.4 1 5.9   
   Missing 1 0.4 1 0.4 0 0.0   
Alcohol Consumption           0.87 
   None 49 18.4 47 18.8 2 11.8   
   Rare 158 59.2 147 58.8 11 64.7   
   >1 Drink/day 56 21.0 52 20.8 4 23.5   
   Missing 4 1.5 4 1.6 0 0.0   
Smoking History           0.59 
   Current Smoker 14 5.2 13 5.2 1 5.9   
   Past Smoker 135 50.6 124 49.6 11 64.7   
   Never Smoked 114 42.7 109 43.6 5 29.4   
   Missing 4 1.5 4 1.6 0 0.0   
Stage of cancer           1.00 
   Stage I 126 47.2 118 47.2 8 47.1   
   Stage II 115 43.1 107 42.8 8 47.1   
   Stage III 24 9.0 23 9.2 1 5.9   
   Missing 2 0.8 2 0.8 0 0.0   
Years Since Diagnosis           0.07 
   <5 years 99 37.1 97 38.8 2 11.8   
   5-10 years 126 47.2 116 46.4 10 58.8   
   >10 years 41 15.4 36 14.4 5 29.4   
   Missing 1 0.4 1 0.4 0 0.0   
Lymph Node Involvement           0.75 
    No 177 66.3 164 65.6 13 76.5   
    Yes 83 31.1 79 31.6 4 23.5   
    Missing 7 2.6 7 2.8 0 0.0   
Surgical Treatment           0.61 
    Lumpectomy 172 64.4 162 64.8 10 58.8   
    Mastectomy 95 35.6 88 35.2 7 41.2   
Chemotherapy           0.81 
    No 108 40.5 102 40.8 6 35.3   
    Yes 158 59.2 147 58.8 11 64.7   
    Missing 1 0.4 1 0.4 0 0.0   
Hormonal Treatment           0.07 
    No 52 19.5 45 18.0 7 41.2   
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    Yes 212 79.4 202 80.8 10 58.8   
    Missing 3 1.1 3 1.2 0 0.0   
Radiation Treatment           0.45 
   No 57 21.4 52 20.8 5 29.5   
   Yes 208 77.9 196 78.4 12 70.6   
   Missing 2 0.8 2 0.8 0 0.0   
ER Status           0.17 
   Negative 48 18.0 42 16.8 6 35.3   
   Positive 213 79.8 202 80.8 11 64.7   
   Missing 6 2.3 6 2.4 0 0.0   
PR Status            0.50 
   Negative 68 25.5 62 24.8 6 35.3   
   Positive 187 70.0 176 70.4 11 64.7   
   Missing 12 4.5 12 4.8 0 0.0   
Local Perceived Recurrence Risk           0.31 
   0-10% 127 47.6 118 47.2 9 52.9   
 10-30% 86 32.2 79 31.6 7 41.2   
  >30% 54 20.2 53 21.2 1 5.9   
Distant Perceived Recurrence Risk           0.40 
   0-10% 89 33.3 81 32.4 8 47.1   
 10-30% 97 36.3 91 36.4 6 35.3   
  >30% 81 30.3 78 31.2 3 17.7   
Adjuvant! Online Risk Score           0.39 
   0-10% 95 35.6 92 36.8 3 17.7   
 10-30% 142 53.2 130 52.0 12 70.6   
  >30% 27 10.1 25 10.0 2 11.8   
  Missing 3 1.1 3 1.2 0 0.0   
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Table 2. Descriptive statistics for missing women (n=34): Breast Cancer Survivorship 
Study, 2008 (continued on next page) 
              Mean SD P-Value 
Age (years) 67.48 11.3  0.00 
  
N %   
Race   0.59 
    Non-White 2 5.9   
    White 26 76.5   
    Missing 6 17.7   
Socioeconomic status   0.02 
   <$25,000/year 9 26.5   
   25,000-50,000/year 4 11.8   
   50,000-100,000/year 5 14.7   
   >100,000/year 1 2.9   
   Missing 15 44.1   
Educational Level    0.16 
   High School or less 13 38.2   
   College 6 17.7   
   Post Graduate 5 14.7   
   Missing 10 29.4   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  
  
   None 18 52.9 0.56 
   One or more 7 20.6   
   Missing 9 26.5   
Alcohol Consumption   0.14 
   None 8 23.5   
   Rare 10 29.4   
   >1 Drink/day 6 17.7   
   Missing 10 29.4   
Smoking History   0.32 
   Current Smoker 2 5.9   
   Past Smoker 9 26.5   
   Never Smoked 13 38.2   
   Missing 10 29.4   
Stage of cancer   0.01 
   Stage I 24 70.6   
   Stage II 9 26.5   
   Stage III 0 0.0   
   Missing 1 2.9   
Years Since Diagnosis   0.85 
   <5 years 8 23.5   
   5-10 years 13 38.2   
   >10 years 4 11.8   
   Missing 9 26.5   
Lymph Node Involvement   0.10 
    No 26 76.5   
    Yes 5 14.7   
    Missing 3 8.8   
Surgical Treatment   0.70 
    Lumpectomy 23 67.7   
    Mastectomy 10 29.4   
    Missing 1 2.9   
Chemotherapy   0.00 
    No 23 67.7   
    Yes 9 26.5   
    Missing 2 5.9   
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Hormonal Treatment   0.16 
    No 6 17.7   
    Yes 26 76.5   
    Missing 2 5.9   
Radiation Treatment   0.34 
   No 8 23.5   
   Yes 25 73.5   
   Missing 1 2.9   
ER Status   0.06 
   Negative 3 8.8   
   Positive 28 82.4   
   Missing 3 8.8   
PR Status    0.22 
   Negative 8 23.5   
   Positive 22 64.7   
   Missing 4 11.8   
Local Perceived Recurrence Risk   0.00 
   0-10% 15 44.1   
 10-30% 4 11.8   
  >30% 1 2.9   
  Missing 14 41.2   
Distant Perceived Recurrence Risk   0.04 
   0-10% 12 35.3   
 10-30% 3 8.8   
  >30% 4 11.8   
  Missing 15 44.1   
Adjuvant! Online Risk Score 0.01 
   0-10% 11 32.4   
 10-30% 20 58.8   
  >30% 0 0.0   
  Missing 3 8.8   
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Table 3. Distribution of behavior change among participants (n=267): Breast Cancer 
Survivorship Study, 2008 
  N % 
Alcohol    
   No Change 223 83.5 
   Change    
       Positive 33 12.4 
       Negative 8 3.0 
       Unclassifiable 3 1.1 
Exercise    
   No Change 121 45.3 
   Change   
       Positive 90 33.7 
       Negative 47 17.6 
       Unclassifiable 9 3.4 
Nutrition   
   No Change 127 47.6 
   Change    
       Positive 116 43.5 
       Negative 10 3.8 
       Unclassifiable 14 5.2 
Smoking    
   No Change 235 88.0 
   Change    
       Positive 24 9.0 
       Negative 4 1.5 
       Unclassifiable 4 1.5 
Sun Exposure   
   No Change 152 56.9 
   Change    
       Positive 99 37.1 
       Negative 8 8.0 
       Unclassifiable 8 8.0 
Supplement Use   
   No Change 130 48.7 
   Change   
       Positive 96 36.0 
       Negative 18 6.7 
       Unclassifiable 23 8.6 
Weight   
   No Change 109 40.8 
   Change   
       Positive 53 19.9 
       Negative 88 33.0 
       Unclassifiable 17 6.4 
Any Change   
   No 17 6.4 
   Only Positive  117 43.8 
   Only Negative 25 9.4 
   Both Positive and Negative 89 33.3 
   Unclassifiable 19 7.1 
Any Positive Change   
   At least 1 206 77.2 
   No 61 22.9 
Any Negative Change   
   At least 1 114 42.7 
   No 153 57.3 
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Table 4. Descriptive statistics for those women who made no positive changes (n=61): Breast 
Cancer Survivorship Study, 2008 (continued on next page) 
              Mean SD P-Value 
Age (years) 59.79 10.8 0.95 
  
N %   
Race   0.28 
    Non-White 7 11.5   
    White 54 88.5   
Socioeconomic status   0.62 
   <$25,000/year 13 21.3   
   25,000-50,000/year 14 23.0   
   50,000-100,000/year 15 24.6   
   >100,000/year 14 23.0   
   Missing 5 8.2   
Educational Level    0.88 
   High School or less 21 34.4   
   College 24 39.3   
   Post Graduate 16 26.2   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  0.40 
   None 48 78.7   
   One or more 13 21.3   
   Missing 0 0.0   
Alcohol Consumption   0.77 
   None 8 13.1   
   Rare 38 62.3   
   >1 Drink/day 14 23.0   
   Missing 1 1.6   
Smoking History   0.62 
   Current Smoker 4 6.6   
   Past Smoker 28 45.9   
   Never Smoked 27 44.3   
   Missing 2 3.3   
Stage of cancer   0.50 
   Stage I 31 50.8   
   Stage II 28 45.9   
   Stage III 2 3.3   
   Missing 0 0.0   
Years Since Diagnosis   0.83 
   <5 years 20 32.8   
   5-10 years 31 50.8   
   >10 years 10 16.4   
   Missing 0 0.0   
Lymph Node Involvement   0.73 
    No 44 72.1   
    Yes 16 26.2   
    Missing 1 1.6   
Surgical Treatment   0.46 
    Lumpectomy 43 70.5   
    Mastectomy 18 29.5   
Chemotherapy   0.82 
    No 23 37.7   
    Yes 38 62.3   
    Missing 0 0.0   
Hormonal Treatment   0.62 
    No 15 24.6   
    Yes 46 75.4   
    Missing 0 0.0   
21 
 
Radiation Treatment   0.62 
   No 12 19.7   
   Yes 48 78.7   
   Missing 1 0.0   
ER Status   0.59 
   Negative 13 21.3   
   Positive 48 78.7   
   Missing 0 0.0   
PR Status    0.72 
   Negative 16 26.2   
   Positive 44 72.1   
   Missing 1 1.6   
Local Perceived Recurrence Risk   0.08 
   0-10% 33 54.1   
 10-30% 23 37.7   
  >30% 5 8.2   
Distant Perceived Recurrence Risk   0.43 
   0-10% 25 41.0   
 10-30% 22 36.1   
  >30% 14 23.0   
Adjuvant! Online Risk Score   0.88 
   0-10% 19 31.2   
 10-30% 35 57.4   
  >30% 7 11.5   
  Missing 0 0.0   
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Table 5. Frequencies and odds ratios of behavior change by local perceived recurrence risk:  
Breast Cancer Survivorship Study, 2008 
  <10% 10-30% >30% P-Trend 
Any Change         
  No 9 7 1   
  Yes 118 79 53   
  Unadjusted 1.0 .9 (.3, 2.4) 4.0 (.5, 32.7)   
  Adjusteda 1.0 .9(.3, 2.5) 3.6 (.4, 29.4) 0.35 
Alcohol         
  No 103 74 46   
  Yes 24 12 8   
  Unadjusted 1.0 0.7 (.3, 1.5) 0.8 (.3, 1.8)   
  Adjustedb 1.0 0.6 (.3, 1.4) 0.8 (.3, 2.2) 0.52 
Exercise         
  No 60 40 21   
  Yes 67 46 33   
  Unadjusted 1.0 1.0 (.6, 1.8) 1.4 (.7, 2.7)   
  Adjustedc 1.0 1.0 (.6, 1.8) 1.4 (.7, 2.7) 0.39 
Nutrition         
  No 73 37 17   
  Yes 54 49 37   
  Unadjusted 1.0 1.8 (1.0, 3.1) 2.9 (1.5, 5.8)   
  Adjustedd 1.0 1.9 (1.0, 3.3) 3.1 (1.6, 6.3) 0.00 
Smoking         
  No 114 74 47   
  Yes 13 12 7   
  Unadjusted 1.0 1.4 (.6, 3.3) 1.3 (.5, 3.5)   
  Adjustede 1.0 1.8 (.6, 5.1)  2.6 (.8, 8.7) 0.11 
Sun Exposure         
  No 77 51 24   
  Yes 50 35 30   
  Unadjusted 1.0 1.1 (.6, 1.9) 1.9 (1.0, 3.7)   
  Adjustedf 1.0 0.9  (.5, 1.6) 1.8 ( 0.9, 3.6) 0.22 
Supplement Use         
  No 66 39 25   
  Yes 61 47 29   
  Unadjusted 1.0 1.3 (.8, 2.3) 1.3 (.7, 2.4)   
  Adjustedg 1.0 1.2 (.6, 2.1) 1.4 (.7, 2.9) 0.46 
Weight         
  No 56 35 18   
  Yes 71 51 36   
  Unadjusted 1.0 1.2 (.7, 2.0) 1.6 (.8, 3.1)   
  Adjustedh 1.0 1.1 (.6, 2.0) 1.4 (.7, 2.7) 0.45 
Any Positive Change         
  No 33 23 5   
  Yes 94 63 49   
  Unadjusted 1.0 1.0 (.5, 1.8) 3.4 (1.3, 9.4) 0.04 
Any Negative Change   
  No 75 46 32   
  Yes 52 40 22   
  Unadjusted 1.0 1.3 (.7, 2.2) 1.0  (.5, 1.9)   
  Adjustedi 1.0 1.3(.7, 2.2) 1.0 (.5, 2.0) 0.82 
a)  adjusted for family history of cancer (1st degree) and surgical treatment 
b)  adjusted for smoking status, income, alcohol use, and age 
c) adjusted for age 
d) adjusted for age and alcohol use 
e) adjusted for age, smoking status, and race 
f) adjusted for stage of cancer, radiation treatment, and chemotherapy treament 
g) adjusted for education, years since diagnosis, and lymph node involvement 
h) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment 
i) adjusted for stage of cancer and chemotherapy treatment 
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Table 6. Frequencies and odds ratios of behavior change by distant perceived recurrence 
risk:  Breast Cancer Survivorship Study, 2008 
  <10% 10-30% >30% P-Trend 
Any Change   
  No 8 6 3   
  Yes 81 91 78   
  Unadjusted 1.0 1.5 (.5, 4.5) 2.6 (.7, 10.0)   
  Adjusteda 1.0 1.8 (.6, 5.4) 2.7 (.7, 10.6) 0.15 
Alcohol   
  No 76 81 66   
  Yes 13 16 15   
  Unadjusted 1.0 1.2 (.5, 2.6) 1.3 (.6, 3.0)   
  Adjustedb 1.0 1.0 (.4, 2.4) 1.1 (.5, 2.8) 0.67 
Exercise   
  No 45 44 32   
  Yes 44 53 49   
  Unadjusted 1.0 1.2 (.7, 2.2) 1.6 (.9, 2.9)   
  Adjustedc 1.0 1.2 (.6, 2.1) 1.5 (.8,  2.8) 0.20 
Nutrition      
  No 47 49 31   
  Yes 42 48 50   
  Unadjusted 1.0 1.1 (.6, 2.0) 1.8 (1.0, 3.3)   
  Adjustedd 1.0 1.0 (.6, 1.8) 1.8 (1.0, 3.4) 0.08 
Smoking   
  No 81 84 70   
  Yes 8 13 11   
  Unadjusted 1.0 1.6 (.6, 4.0) 1.6 (.6, 4.2)   
  Adjustede 1.0 1.8 (.5, 6.8) 2.3 (.6, 8.5) 0.24 
Sun Exposure   
  No 60 54 38   
  Yes 29 43 43   
  Unadjusted 1.0 1.7 (.9, 3.0) 2.3 (1.3, 4.4)   
  Adjustedf 1.0 2.1 (1.1, 4.1) 2.5 (1.2, 5.0) 0.01 
Supplement Use   
  No 47 48 35   
  Yes 42 49 46   
  Unadjusted 1.0 1.1 (.6, 2.0) 1.5 (.8, 2.7)   
  Adjustedg 1.0 0.9 (.5,  1.6) 1.3 (.7, 2.5) 0.60 
Weight   
  No 43 41 25   
  Yes 46 56 56   
  Unadjusted 1.0 1.3 (.7, 2.3) 2.1 (1.1, 3.9)   
  Adjustedh 1.0 1.1 (.6, 2.1) 1.6 (.8, 3.2) 0.14 
Any Positive Change   
  No 25 22 14   
  Yes 64 75 67   
  Unadjusted 1.0 1.3 (.7, 2.6) 1.9 (.9, 3.9) 0.04  
Any Negative Change   
  No 57 57 39   
  Yes 32 40 42   
  Unadjusted 1.0 1.3 (.7, 2.3) 1.9 (1.0, 3.6)   
  Adjustedi 1.0 1.2 (.6, 2.1) 1.9 (1.0, 3.5) 0.06 
a)  adjusted for family history of cancer (1st degree) and surgical treatment 
b)  adjusted for smoking status, alcohol use, and age 
c) adjusted for age 
d) adjusted for age and alcohol use 
e) adjusted for race, alcohol use, smoking status, lymph node involvement, and pr status 
f) adjusted for  family history, stage of cancer, chemotherapy treament, radiation treatment, and pr status 
g) adjusted for education, years since diagnosis, and lymph node involvement 
h) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment 
i) adjusted for chemotherapy treatment and radiation treatment 
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Table 7. Odds ratios of behavior change by local perceived recurrence risk stratified by years since diagnosis:  Breast Cancer 
Survivorship Study, 2008 
  <5 years 5-10 years >10 years 
  
<10% 10-30% >30% <10% 10-30% >30% <10% 10-30% >30% 
Any Change           
  No 0 2 0 5 5 0 4 0 1 
  Yes 46 29 22 53 43 20 19 7 10 
  Unadjusted 1.0 1.0 1.0 1.0 .8 (.2, 3.0) 1.0 1.0 1.0 2.1 (.2, 21.5) 
  Adjusteda 1.0 1.0 1.0 1.0 .7 (.2, 2.8) 1.0 1.0 1.0 2.1 (.2, 22.0) 
Alcohol           
  No 35 29 17 47 39 17 21 6 11 
  Yes 11 2 5 11 9 3 2 1 0 
  Unadjusted 1.0 .2 (.1, 1.1) .9 (.3, 3.1) 1.0 .99 (.37, 2.6) .75 (.19, 3.0) 1.0 1.8 (.1, 22.8) 1.0 
  Adjustedb 1.0 .3 (.1, 1.5) 1.0 (.2, 3.9) 1.0 .89 (.30, 2.6) 1.1 (.25, 4.7) 1.0 7.2 (.1, 654.1) 1.0 
Exercise           
  No 20 15 9 31 21 8 9 4 4 
  Yes 26 16 13 27 27 12 14 3 7 
  Unadjusted 1.0 .8 (.3, 2.1) 1.1 (.4, 3.1) 1.0 1.5 (.7, 3.2) 1.7 (.6, 4.8) 1.0 .5 (.1, 2.7) 1.1 (.3, 50) 
  Adjustedc 1.0 .9 (.4, 2.4) 1.1 (.4, 3.1) 1.0 1.5 (.7, 3.2) 1.7 (.6, 4.9) 1.0 .5 (.1, 2.8) 1.0 (.2, 4.7) 
Nutrition            
  No 23 13 10 37 20 3 13 4 4 
  Yes 23 18 12 21 28 17 10 3 7 
  Unadjusted 1.0 1.4 (.6, 3.5) 1.2 (.4, 3.3) 1.0 2.5 (1.1, 5.4) 10.0 (2.6, 38.1) 1.0 1.0 (.2, 5.4) 2.3 (.5, 10.0) 
  Adjustedd 1.0 1.7 (.6, 4.7) 1.1 (.4, 3.3) 1.0 2.6 (1.2, 6.0) 15.5 (3.2, 75.0) 1.0 1.1 (.2, 6.8) 1.8 (.4, 8.8) 
Smoking           
  No 42 29 19 52 40 18 20 5 9 
  Yes 4 2 3 6 8 2 3 2 2 
  Unadjusted 1.0 .7 (.1, 4.2) 1.7 (.3, 8.2) 1.0 1.7 (.6, 5.4) 1.0 (.2, 5.2) 1.00 2.7 (.3, 20.5) 1.5 (.2, 10.5) 
  Adjustede 1.0 1.2 (.1, 14.5) 4.3 (.4, 49.4) 1.0 2.1 (.5, 8.6) 2.2 (.3, 14.8) 1.00 1.8 (.2, 20.9) 2.4 (.2, 36.2) 
Sun Exposure           
  No 25 18 13 34 28 5 18 5 5 
  Yes 21 13 9 24 20 15 5 2 6 
  Unadjusted 1.0 .9 (.3, 2.2) .8 (.3, 2.3) 1.0 1.0 (.5, 2.2) 4.3 (1.4, 13.3) 1.0 1.4 (.2, 9.8) 4.3 (.9, 20.3) 
  Adjustedf 1.0 .7 (.3, 1.9) .9 (.3, 2.8) 1.0 .8 (.3, 1.8) 3.4 (1.0, 11.4) 1.0 1.5 (.2, 12.7) 2.3 (.3, 16.0) 
Supplement Use         
  No 17 8 7 34 26 9 15 5 9 
  Yes 29 23 15 24 22 11 8 2 2 
  Unadjusted 1.0 1.7 (.6, 4.6) 1.3 (.4, 3.7) 1.0 1.2 (.6, 2.6) 1.7 (.6, 4.8) 1.0 .8 (.1, 4.8) .4  (.1, 2.4) 
  Adjustedg 1.0 1.6 (.6, 4.5) 1.4 (.5,  4.1) 1.0 1.0 (.4, 2.12 1.3 (.4, 3.9) 1.0 1.1 (.1, 8.2) .7 (.1, 5.08) 
Weight       
  No 19 11 8 24 21 3 13 3 7 
  Yes 27 20 14 34 27 17 10 4 4 
  Unadjusted 1.0 1.3 (.5, 3.3) 1.2 (.4, 3.5) 1.0 .9 (.4, 2.0) 4.0 (1.1, 15.2) 1.0 1.7 (.3, 9.6) .7 (.2, 3.3) 
  Adjustedh 1.0 1.3 (.5, 3.3) 1.1 (.4, 3.1) 1.0 .8 (.3, 1.7) 3.2 (.8, 12.3) 1.0 2.0 (.3, 12.4) .5 (.1, 2.7) 
Any Positive Change           
  No 8 8 4 17 14 0 8 1 1 
  Yes 38 23 18 41 34 20 15 6 10 
  Unadjusted 1.0 .6 (.2, 1.8) 1.0 (.3, 3.6) 1.0 1.0 (.4, 2.3) 1.0 1.0 3.2 (.3, 31.4) 5.3 (.6, 49.5) 
Any Negative Change           
  No 23 21 11 36 22 12 16 3 8 
  Yes 23 10 11 22 26 8 7 4 3 
  Unadjusted 1.0 .5 (.2, 1.2) 1.0 (.4, 2.8) 1.0 1.9 (.9, 4.2) 1.1 (.4, 3.1) 1.0 3.1 (.5, 17.4) .9 (.2, 4.2) 
  Adjustedi 1.0 .5 (.2, 1.2) .8 (.3, 2.3) 1.0 1.8 (.8, 3.9) .9 (.3, 2.6) 1.0 3.7 (.6, 23.2) 1.2 (.2, 6.9) 
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Table 8. Odds ratios of behavior change by distant perceived recurrence risk stratified by years since diagnosis:  Breast Cancer 
Survivorship Study, 2008 
  
<5 years 5-10 years >10 years 
  <10% 10-30% >30% <10% 10-30% >30% <10% 10-30% >30% 
Any Change           
  No 0 1 1 5 3 2 3 2 0 
  Yes 26 37 34 38 45 33 17 9 10 
  Unadjusted 1.0 1.1 (.1, 18.1) 1.0 1.0 2.0  (.4, 8.8) 2.2 (.4, 11.9) 1.0 .8 (.1, 5.7) 1.0 
  Adjusteda 1.0 1.1 (.1, 19.9) 1.0 1.0 2.3 (.5, 10.6) 1.8 (.3, 10.6) 1.0 .9 ( .1, 6.6) 1.0 
Alcohol           
  No 23 31 27 35 40 28 18 10 10 
  Yes 3 7 8 8 8 7 2 1 0 
  Unadjusted 1.0 1.7 (.4, 7.4) 2.3 (.5, 9.6) 1.0 .9 (.3, 2.6) 1.1 (.4, 3.4) 1.0 .9 (.1, 11.2) 1.0 
  Adjustedb 1.0 1.6 (.3, 8.2) 2.2 (.5, 11.1) 1.0 1.1 (.3, 3.4) 1.2 (.3, 4.0) 1.0 1.1 (0.0, 44.1) 1.0 
Exercise           
  No 12 15 17 26 22 12 7 7 3 
  Yes 14 23 18 17 26 23 13 4 7 
  Unadjusted 1.0 1.3 (.5, 3.6) .9 (.3, 2.5) 1.0 1.8 (.8, 4.2) 2.9 (1.2, 7.4) 1.0 .3 (.1, 1.4) 1.3 (.2, 6.5) 
  Adjustedc 1.0 1.3 (.4, 3.7) .9 (.3, 2.7) 1.0 1.8 (.8, 4.1) 2.9 (1.1, 7.4) 1.0 .3 (.1, 1.4) 1.1 (.2, 5.9) 
Nutrition            
  No 11 16 19 24 25 11 12 8 1 
  Yes 15 22 16 19 23 24 8 3 9 
  Unadjusted 1.0 1.0 (.4, 2.8) .6 (.2, 1.7) 1.0 1.2 (.5, 2.7) 2.8 (1.1, 7.0) 1.0 .6 (.1, 2.8) 13.5 (1.4, 128.3) 
  Adjustedd 1.0 1.0 (.4, 3.0) .7 (.2, 1.9) 1.0 1.0 (.4, 2.5) 2.8 (1.1, 7.5) 1.0 .4 (.1, 2.4) 13.4 (1.2, 145.2) 
Smoking           
  No 24 35 31 39 41 30 18 8 8 
  Yes 2 3 4 4 7 5 2 3 2 
  Unadjusted 1.0 1.0 (.2, 6.6) 1.6 (.3, 9.2) 1.0 1.7 (.5, 6.1) 1.6 (.4, 6.6) 1.0 3.4 (.5, 24.3) 2.3 (.3, 18.9) 
  Adjustede 1.0 .6 (.1, 4.9) 1.8 (.3, 11.1) 1.0 1.6 (.4, 6.7) 1.5 (.3, 6.7) 1.0 5.1 (.1, 262.6) 13.5 (.1, 1971.4) 
Sun Exposure           
  No 16 21 19 29 25 13 15 8 5 
  Yes 10 17 16 14 23 22 5 3 5 
  Unadjusted 1.0 1.3 (.5, 3.6) 1.4 (.5, 3.8) 1.0 1.9 (.8, 4.5) 3.5 (1.4, 8.9) 1.0 1.1 (.2, 6.0) 3.0 (.6, 14.9) 
  Adjustedf 1.0 1.8 (.6, 5.7) 1.9 (.6, 6.2) 1.0 2.2 (.9, 5.5) 3.4 (1.2, 9.7) 1.0 2.8 (.3, 24.1) 2.6 (.2, 27.6) 
Supplement Use           
  No 10 10 12 23 29 17 14 9 6 
  Yes 15 28 23 20 19 18 6 2 4 
  Unadjusted 1.0 1.8 (.6, 5.1) 1.2 (.4, 3.4) 1.0 .8 (.3, 1.7) 1.2 (.5, 3.0) 1.0 .5 (.1, 3.2) 1.6 (.3, 7.6) 
  Adjustedg 1.0 1.7 (.6, 5.1) 1.3 (.4, 3.8) 1.0 .7 (.3, 1.6) 1.0 (.4, 2.5) 1.0 .2 (0.0, 2.1) 2.9 (.4, 20.8) 
Weight           
  No 11 14 13 22 19 7 10 8 5 
  Yes 15 24 22 21 29 28 10 3 5 
  Unadjusted 1.0 1.3 (.5, 3.5) 1.2 (.4, 3.5) 1.0 1.6 (.7, 3.7) 4.2 (1.5, 11.6) 1.0 .4 (.1, 1.8) 1.0 (.2, 4.6) 
  Adjustedh 1.0 1.1 (.4, 3.2) 1.1 (.4, 3.2) 1.0 1.5 (.6, 3.5) 3.4 (1.2, 9.8) 1.0 .5 (.1, 2.6) .8 (.2, 4.2) 
Any Positive Change           
  No 5 5 10 14 13 4 6 4 0 
  Yes 21 33 25 29 35 31 14 7 10 
  Unadjusted 1.0 1.6 (.4, 6.1) .6 (.2, 2.0) 1.0 1.3 (.5, 3.2) 3.7 (1.1, 12.7) 1.0 .8 (.2, 3.6) 1.0 
Any Negative Change           
  No 15 23 17 29 25 16 13 9 5 
  Yes 11 15 18 14 23 19 7 2 5 
  Unadjusted 1.0 .9 (.3, 2.5) 1.4 (.5, 2.5) 1.0 1.9 (.8, 4.5) 2.5 (1.0, 6.2) 1.0 .4 (.1, 2.5) 1.9 (.4, 8.7) 
  Adjustedi 1.00 .7 (.3, 2.1) 1.2 (.4, 3.5) 1.0 1.7 (.7, 4.1) 2.1 (.8, 5.4) 1.0 .4 (.1, 2.9) 2.9 (.5, 15.9) 
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Table 9. Multinomial Regression for direction of Behavior Change, Local Perceived Recurrence Risk: Breast Cancer Survivorship Study, 2008 
  N No Change N Negative Change Adjusted P-Trend N Positive Change Adjusted P-Trend 
           OR  OR 95% CI OR 95% CI   OR 95% CI OR 95% CI   
Alcohol    
          0-10% Recurrence Risk  103 1.0 4 1.0     17 1.0   
        10-30% Recurrence Risk 74 1.0 3 1.0 (.23, 4.8) 1.1 (.2, 5.2)  9 0.7 (.3, 1.7) 0.6 (.3, 1.6)   
        >30%  Recurrence Risk 46 1.0 1 0.6 (.06, 5.2) 0.5 (.04, 5.2) 0.63 7 0.9 (.4, 2.4) 1.0 (.4,  2.7) 0.80 
Exercise            
          0-10% Recurrence Risk    60 1.0 22 1.0     37 1.0   
        10-30% Recurrence Risk 40 1.0 17 1.2 (.6, 2.5) 1.2 (.5, 2.4) 28 1.1 (.6, 2.1) 1.1 (.6, 2.1)   
        >30%  Recurrence Risk 21 1.0 8 1.0 (.4, 2.7) 1.0 (.4, 2.6) 0.90 25 1.9 (1.0, 3.9) 1.9 (.9, 3.9) 0.10 
Nutrition     
          0-10% Recurrence Risk    73 1.0 4 1.0 41 1.0   
        10-30% Recurrence Risk 37 1.0 4 2.0 (.5, 8.3 2.2 (.5, 9.6) 40 1.9 (1.1, 3.5) 2.1 (1.1, 3.8)   
        >30%  Recurrence Risk 17 1.0 2 2.2 (.4,  12.7) 2.4 (.4, 14.2) 0.26 35 3.7 (1.9, 7.4) 4.0 (1.9, 8.2) 0.00 
Smoking     
          0-10% Recurrence Risk 114 1.0 1 1.0 9 1.0   
        10-30% Recurrence Risk 74 1.0 1 1.5 (.1, 25.0) 3.6 (.1, 91.8) 10 1.7 (.7, 4.4) 2.1 (.7, 6.3)   
         >30% Recurrence Risk 47 1.0 2 4.9 (.4, 54.8) 21.4 (.7, 654.1) 0.08 5 1.4 (.4, 4.2) 2.6 (.7, 9.6) 0.13 
Sun Exposure     
          0-10% Recurrence Risk  77 1.0 5 1.0 42 1.0   
        10-30% Recurrence Risk 51 1.0 1 0.3 (.03, 2.7) 0.2 (.03, 2.1) 31 1.1 (.6, 2.0) 0.9 (.5, 1.7)   
        >30%  Recurrence Risk 24 1.0 2 1.3 (.2, 7.0) 1.1 (.2, 6.6) 0.80 26 2.0 (1.0 3.9) 1.7 (.8, 3.6) 0.20 
Supplement Use     
          0-10% Recurrence Risk  66 1.0 12 1.0 40 1.0   
        10-30% Recurrence Risk 39 1.0 5 0.7 (.2, 2.2) 0.6 (.2, 1.8) 35 1.5 (.8, 2.7) 1.3 (.7, 2.6)   
        >30%  Recurrence Risk 25 1.0 1 0.2 (.03, 1.8) 0.2 (.02, 1.7) 0.09 21 1.4 (.7, 2.8) 1.5 (.7, 3.2) 0.29 
Weight     
          0-10% Recurrence Risk   56 1.0 37 1.0 25 1.0   
        10-30% Recurrence Risk 35 1.0 33 1.4 (.8, 2.7) 1.3 (.7, 2.5) 14 0.9 (.4, 2.0) 0.9 (.4, 1.9)   
        >30%  Recurrence Risk 18 1.0 18 1.5 (.7, 3.3) 1.2 (.6, 2.8) 0.52 14 1.7 (.8, 4.1) 1.6 (.7, 3.7) 0.42 
a)  adjusted for smoking status, income, alcohol use, and age   
b) adjusted for age   
c) adjusted for age and alcohol use   
d) adjusted for age, smoking status, and race   
e) adjusted for stage of cancer, radiation treatment, and chemotherapy treatment   
f) adjusted for education, years since diagnosis, and lymph node involvement   
g) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment   
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Table 10. Multinomial Regression for direction of Behavior Change, Distant Perceived Recurrence Risk: Breast Cancer Survivorship Study, 2008 
  
N No 
Change 
N Negative Change Adjusted P-
Trend 
N Positive Change Adjusted P-
Trend 
           OR  OR 95% CI OR 95% CI   OR 95% CI OR 95% CI   
Alcohola    
          0-10% Recurrence Risk  76 1.0 1 1.0     10 1.0   
        10-30% Recurrence Risk 81 1.0 2 1.9 (.2, 21.1) 1.8 (.2, 21.2)  13 1.2 (.5, 3.0) 1.09 (.4, 2.7)   
        >30%  Recurrence Risk 66 1.0 5 5.8 (.7, 50.5) 5.4 (.6, 50.6) 0.10 10 1.2 (.5, 2.9) 0.96 (.4, 2.6) 0.95 
Exerciseb            
          0-10% Recurrence Risk    45 1.0 12 1.0     26 1.0   
        10-30% Recurrence Risk 44 1.0 19 1.6 (.7, 3.7) 1.5 (.6, 3.5) 31 1.2 (.6, 2.4) 1.16 (.6, 2.3)   
        >30%  Recurrence Risk 32 1.0 16 1.9 (.8, 4.5) 1.8 (.7, 4.3) 0.21 33 1.8 (.9, 3.5) 1.72 (.9, 3.4) 0.12 
Nutritionc     
          0-10% Recurrence Risk    47 1.0 0 1.0 33 1.0   
        10-30% Recurrence Risk 49 1.0 5 277824.0  3361584.0   40 1.2 (.6, 2.1) 1.10 (.6, 2.1)   
        >30%  Recurrence Risk 31 1.0 5 439140.0  5872987.0  0.03 43 2.0 (1.0, 3.8) 2.02 (1.0, 3.9) 0.05 
Smokingd     
          0-10% Recurrence Risk 81 1.0 1 1.0 6 1.0   
        10-30% Recurrence Risk 84 1.0 1 1.0 (.1, 15.7) 1.6 (.1, 37.2) 9 1.5 (.5, 4.3) 1.39 (.3, 5.7)   
         >30% Recurrence Risk 70 1.0 2 2.3 (.2, 26.1) 1.1 (0.0, 33.3) 0.94 9 1.7 (.6, 5.1) 2.20 (.5, 8.9) 0.26 
Sun Exposuree     
          0-10% Recurrence Risk  60 1.0 0 1.0 27 1.0   
        10-30% Recurrence Risk 54 1.0 6 5107638.0  1.01 E07   34 1.4 (.7, 2.6) 1.90 (.9, 3.8)   
        >30%  Recurrence Risk 38 1.0 2 2418342.0  882898.8  0.35 38 2.2 (1.2, 4.2) 2.52 (1.2, 5.2) 0.01 
Supplement Usef     
          0-10% Recurrence Risk  47 1.0 6 1.0 28 1.0   
        10-30% Recurrence Risk 48 1.0 6 1.0 (.3, 3.3) 0.7 (.2, 2.4) 37 1.3 (.7, 2.4) 0.99 (.5, 2.0)   
        >30%  Recurrence Risk 35 1.0 6 1.3 (.4, 4.6) 0.9 (.3, 3.4) 0.92 31 1.5 (.8, 2.9) 1.18 (.6, 2.5) 0.67 
Weightg     
          0-10% Recurrence Risk   43 1.0 25 1.0 16 1.0   
        10-30% Recurrence Risk 41 1.0 31 1.3 (.7, 2.6) 1.1 (.5, 2.2) 19 1.3 (.6, 2.8) 1.13 (.5, 2.5)   
        >30%  Recurrence Risk 25 1.0 32 2.2 (1.1, 4.5) 1.6 (.8, 3.5) 0.22 18 1.9 (.8, 4.5) 1.64 (.7, 3.9) 0.28 
a)  adjusted for smoking status, alcohol use, and age   
b) adjusted for age   
c) adjusted for age and alcohol use   
d) adjusted for race, alcohol use, smoking status, lymph node involvement, and pr status 
  
e) adjusted for  family history, stage of cancer, chemotherapy treatment, radiation 
treatment, and pr status 
  
f) adjusted for education, years since diagnosis, and lymph node involvement   
g) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment                   
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Table 11. Concordance of distant perceived recurrence risk (n=267), 
Breast Cancer Survivorship Study, 2008 
 N % 
Accurate 98 37.1 
Overestimated 104 39.4 
Underestimated 62 23.5 
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Table 12. Frequency and odds ratios of behavior change by concordance:  Breast 
Cancer Survivorship Study, 2008 
  Accurate Overestimate Underestimate 
Any Change       
  No 5 4 8 
  Yes 93 100 54 
  Unadjusted 1.0 1.3 (.4, 5.2) .4 (.1, 1.2) 
  Adjusteda 1.0 1.5 (.4, 5.6) .4 (.1, 1.4) 
Alcohol       
  No 85 81 54 
  Yes 13 23 8 
  Unadjusted 1.0 1.9 (.9, 3.9) 1.0 (.4, 2.5) 
  Adjustedb 1.0 1.9 (.8, 4.2) 1.2 (.4, 3.2) 
Exercise       
  No 46 44 30 
  Yes 52 60 32 
  Unadjusted 1.0 1.2 (.7, 2.1) .9 (.5, 1.8) 
  Adjustedc 1.0 1.2 (.7, 2.1) 1.0 (.5, 2.0) 
Nutrition       
  No 46 48 32 
  Yes 52 56 30 
  Unadjusted 1.0 1.0 (.6, 1.8) .8 (.4, 1.6) 
  Adjustedd 1.0 1.0 (.6, 1.8) .8 (.4, 1.6) 
Smoking       
  No 86 91 55 
  Yes 12 13 7 
  Unadjusted 1.0 1.0 (.4, 2.4) .9 (.3, 2.5) 
  Adjustede 1.0 1.0 (.3, 2.9) .8 (.2, 3.0) 
Sun Exposure       
  No 55 55 41 
  Yes 43 49 21 
  Unadjusted 1.0 1.1 (.7, 2.0) .7 (.3, 1.3) 
  Adjustedf 1.0 1.4 (.8, 2.5) .5 (.2, 1.0) 
Supplement Use       
  No 50 46 32 
  Yes 48 58 30 
  Unadjusted 1.0 1.3 (.8, 2.3) 1.0 (.5, 1.8) 
  Adjustedg 1.0 1.1 (.6, 2.0) 1.1 (.5, 2.2) 
Weight       
  No 40 38 30 
  Yes 58 66 32 
  Unadjusted 1.0 1.2 (.7, 2.1) .7 (.4, 1.4) 
  Adjustedh 1.0 1.1 (.6, 2.0) .7 (.4, 1.5) 
Any Positive Change       
  No 22 19 20 
  Yes 76 85 42 
  Unadjusted 1.0 1.3 (.7, 2.6) .6 (3, 1.2) 
Any Negative Change   
  No 52 59 40 
  Yes 46 45 22 
  Unadjusted 1.0 .9 (.5, 1.5) .6  (.3, 1.2) 
  Adjustedi 1.0 .9 (.5, 1.6) .6 (.3, 1.1) 
a)  adjusted for family history of cancer (1st degree) and surgical treatment 
b)  adjusted for smoking status, income, alcohol use, and age 
c) adjusted for age 
d) adjusted for age and alcohol use 
e) adjusted for age, smoking status, and race 
f) adjusted for stage of cancer and chemotherapy treatment 
g) adjusted for education, years since diagnosis, and lymph node involvement 
h) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment 
i) adjusted for stage of cancer and chemotherapy treatment 
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Table 13. Multinomial Regression for direction of Behavior Change, concordance: Breast Cancer Survivorship Study, 2008 
  N No Change N Negative Change Adjusted N Positive Change Adjusted 
           OR  OR 95% CI OR 95% CI  OR 95% CI OR 95% CI 
Alcohola    
    Accurate 85 1.0 1 1.0  1.0  10 1.0 1.0   
    Overestimate 81 1.0 6 6.3 (.7, 53.4) 5.9 (.7, 52.2) 17 1.8 (.8, 4.1) 1.7 (.7, 4.0) 
    Underestimate 54 1.0 1 1.6 (.1, 25.7) 1.5 (.1, 25.3) 6 0.9 (.3, 2.7) 1.0 (.3, 3.0) 
Exerciseb           
    Accurate 46 1.0 17 1.0  1.0  32 1.0 1.0   
    Overestimate 44 1.0 17 1.0 (.5, 2.3) 1.1 (.5, 2.3) 42 1.4 (.7, 2.5) 1.4 (.7, 2.6) 
    Underestimate 30 1.0 12 1.1 (.5, 2.6) 1.2 (.5, 2.9) 15 0.7 (.3, 1.5) 0.8 (.4, 1.7) 
Nutritionc     
    Accurate 46 1.0 6 1.0 1.0 42 1.0 1.0   
    Overestimate 48 1.0 4 0.6 (.2, 2.4) 0.6 (.2, 2.3) 50 1.1 (.6, 2.0) 1.1 (.6, 2.0) 
    Underestimate 32 1.0 0 2.20 E07 3.58 E07 22 0.8 (.4, 1.5) 0.7 (.4, 1.5) 
Smokingd     
    Accurate 86 1.0 1 1.0 1.0 8 1.0 1.0   
    Overestimate 91 1.0 2 1.9 (.2, 21.2) 0.5 (.02, 12.1) 11 1.3 (.5, 3.4) 1.2 (.4, 4.2) 
    Underestimate 55 1.0 1 1.6 (.1, 25.5) 2.1 (.1, 63.1) 5 1.0 (.3, 3.1) 1.0 (.2, 4.4) 
Sun Exposuree     
    Accurate 55 1.0 4 1.0 1.0 36 1.0 1.0   
    Overestimate 55 1.0 4 1.0 (.2, 4.2) 0.9 (.2, 4.4) 43 1.2 (.7, 2.1) 1.5 (.8, 2.8) 
    Underestimate 41 1.0 0 7.13 E07 2.75 E07 18 0.7 (.3, 1.3) 0.5 (.2, 1.1) 
Supplement Usef     
    Accurate 50 1.0 5 1.0 1.0 31 1.0 1.0   
    Overestimate 46 1.0 8 1.7 (.5, 5.7) 1.5 (.4, 5.2) 42 1.5 (.8, 2.7) 1.2 (.6, 2.4) 
    Underestimate 32 1.0 5 1.6 (.4, 5.8) 2.0 (.5, 7.7) 22 1.1 (.5, 2.2) 1.3 (.6, 2.9) 
Weightg     
    Accurate 40 1.0 36 1.0 1.0 18 1.0 1.0   
    Overestimate 38 1.0 35 1.0 (.5, 1.9) 1.0 (.5, 1.9) 24 1.4 (.7, 3.0) 1.2 (.6, 2.7) 
    Underestimate 30 1.0 17 0.6 (.3, 1.3) 0.6 (.3, 1.4) 10 0.7 (.3, 1.8) 0.8 (.3, 1.9) 
a)  adjusted for smoking status, income, alcohol use, and age   
b) adjusted for age   
c) adjusted for age and alcohol use   
d) adjusted for age, smoking status, and race   
e) adjusted for stage of cancer, radiation treatment, and chemotherapy treatment   
f) adjusted for education, years since diagnosis, and lymph node involvement   
g) adjusted for alcohol use, years since diagnosis, and chemotherapy treatment               
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APPENDIX A 
 
 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN ALCOHOL: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in 
Alcohol 
No Change in 
Alcohol 
P-Value 
              Mean SD Mean SD   
Age (years) 55.8 9.1 60.4 9.5 0.00 
  N % N %   
Race     0.19 
    Non-White 5 11.4 13 5.8   
    White 39 88.6 210 94.2   
Socioeconomic status     0.16 
   <$25,000/year 11 25.0 32 14.4   
   25,000-50,000/year 6 13.6 58 26.0   
   50,000-100,000/year 14 31.8 73 32.7   
   >100,000/year 12 27.3 46 20.6   
   Missing 1 2.3 14 6.3   
Educational Level      0.86 
   High School or less 13 29.6 74 33.2   
   College 18 40.9 82 36.8   
   Post-graduate 13 29.6 67 30.0   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
 
0.56 
   None 29 65.9 160 71.8   
   One or more 15 34.1 62 27.8   
   Missing 0 0.0 1 0.5   
Alcohol Consumption     0.02 
   None 4 9.1 45 20.2   
   Rare 23 52.3 135 60.5   
   >1 Drink/day 15 34.1 41 18.4   
   Missing 2 4.6 2 0.9   
Smoking History     0.33 
   Current Smoker 3 6.8 11 4.9   
   Past Smoker 27 61.4 108 48.4   
   Never Smoked 14 31.8 100 44.8   
   Missing 0 0.0 4 1.8   
Stage of cancer     0.43 
   Stage I 17 38.6 109 48.9   
   Stage II 24 54.6 91 40.8   
   Stage III 3 6.8 21 9.4   
   Missing 0 0.0 2 0.9   
Years Since Diagnosis     0.35 
   <5 years 18 40.9 81 36.3   
   5-10 years 23 52.3 103 46.2   
   >10 years 3 6.8 38 17.0   
   Missing 0 0.0 1 0.5   
Lymph Node Involvement     0.68 
    No 29 65.9 148 66.4   
    Yes 15 34.1 68 30.5   
    Missing 0 0.0 7 3.1   
Surgical Treatment     0.73 
    Lumpectomy 27 61.4 145 65.0   
    Mastectomy 17 38.6 78 35.0   
Chemotherapy       
    No 12 27.3 96 43.1 0.14 
    Yes 32 72.7 126 56.5   
    Missing 0 0.0 1 0.5   
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Hormonal Treatment     0.91 
    No 9 20.5 43 19.3   
    Yes 35 79.6 177 79.4   
    Missing 0 0.0 3 1.4   
Radiation Treatment     0.09 
   Negative 11 25.0 57 25.6   
   Positive 33 75.0 154 69.1   
   Missing 0 0.0 12 5.4   
ER Status     0.87 
   Negative 9 20.5 39 17.5   
   Positive 34 77.3 179 80.3   
   Missing 1 2.3 5 2.2   
PR Status     0.35 
   Negative 11 25.0 57 25.6   
   Positive 33 75.0 154 69.1   
   Missing 0 0.0 12 5.4   
Local Perceived Recurrence Risk     0.65 
   0-10% 24 54.6 103 46.2   
 10-30% 12 27.3 74 33.2   
  >30% 8 18.2 46 20.6   
Distant Perceived Recurrence Risk 0.82 
   0-10% 13 29.6 76 34.1   
 10-30% 16 36.4 81 36.3   
  >30% 15 34.1 66 29.6   
Adjuvant! Online Risk Score     0.33 
   0-10% 21 47.7 74 33.2   
 10-30% 20 45.5 122 54.7   
  >30% 3 6.8 24 10.8   
  Missing 0 0.0 3 1.4   
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APPENDIX B 
 
 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN EXERCISE: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in 
Exercise 
No Change in 
Exercise 
P-Value 
              Mean SD Mean SD 
  
Age (years) 58.4 9.2 61.2 9.8 0.01 
  
N % N %   
Race     0.34 
    Non-White 12 8.2 6 5.0   
    White 134 91.8 115 95.0   
Socioeconomic status     0.08 
   <$25,000/year 21 14.4 22 18.2   
   25,000-50,000/year 32 21.9 32 26.5   
   50,000-100,000/year 43 29.5 44 36.4   
   >100,000/year 41 28.1 17 14.1   
   Missing 9 6.2 6 5.0   
Educational Level      0.30 
   High School or less 43 29.5 44 36.4   
   College 54 37.0 46 38.0   
   Post-graduate 49 33.6 31 25.6   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  
0.20 
   None 98 67.1 91 75.2   
   One or more 47 32.2 30 24.8   
   Missing 1 0.7 0 0.0   
Alcohol Consumption     0.94 
   None 25 17.1 24 19.8   
   Rare 87 59.6 71 58.7   
   >1 Drink/day 32 21.9 24 19.8   
   Missing 2 1.4 2 1.7   
Smoking History     0.75 
   Current Smoker 8 5.5 6 5.0   
   Past Smoker 70 48.0 65 53.7   
   Never Smoked 65 44.5 49 40.5   
   Missing 3 2.1 1 0.8   
Stage of cancer     0.97 
   Stage I 69 47.3 57 47.1   
   Stage II 62 42.5 53 43.8   
   Stage III 14 9.6 10 8.3   
   Missing 1 0.7 1 0.8   
Years Since Diagnosis     0.85 
   <5 years 55 37.7 44 36.4   
   5-10 years 66 45.2 60 49.6   
   >10 years 24 16.4 17 14.1   
   Missing 1 0.7 0 0.0   
Lymph Node Involvement     0.91 
    No 95 65.1 82 67.8   
    Yes 47 32.2 36 29.8   
    Missing 4 2.7 3 2.5   
Surgical Treatment     0.80 
    Lumpectomy 93 63.7 79 65.3   
    Mastectomy 53 36.3 42 34.7   
Chemotherapy     0.95 
    No 58 39.7 50 41.3   
    Yes 87 59.6 71 58.7   
    Missing 1 0.7 0 0.0   
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Hormonal Treatment     0.95 
    No 29 19.9 23 19.0   
    Yes 115 78.8 97 80.2   
    Missing 2 1.4 1 0.8   
Radiation Treatment     0.65 
   Negative 38 26.0 30 24.8   
   Positive 99 67.8 88 72.7   
   Missing 9 6.2 3 2.5   
ER Status     0.39 
   Negative 25 17.1 23 19.0   
   Positive 116 79.5 97 80.2   
   Missing 5 3.4 1 0.8   
PR Status     0.35 
   Negative 38 26.0 30 24.8   
   Positive 99 67.8 88 72.7   
   Missing 9 6.2 3 2.5   
Local Perceived Recurrence Risk     0.60 
   0-10% 67 45.9 60 49.6   
 10-30% 46 31.5 40 33.1   
  >30% 33 22.6 21 17.4   
Distant Perceived Recurrence Risk 0.36 
   0-10% 44 30.1 45 37.2   
 10-30% 53 36.3 44 36.4   
  >30% 49 33.6 32 26.5   
Adjuvant! Online Risk Score     0.73 
   0-10% 49 33.6 46 38.0   
 10-30% 78 53.4 64 52.9   
  >30% 17 11.6 10 8.3   
  Missing 2 1.4 1 0.8   
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APPENDIX C 
 
 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE NUTRITION: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in 
Nutrition 
No Change in 
Nutrition 
P-Value 
              Mean SD Mean SD 
  
Age (years) 58.3 8.6 61.2 10.4 0.01 
  
N % N %   
Race     0.48 
    Non-White 11 7.9 7 5.5   
    White 129 92.1 120 94.5   
Socioeconomic status     0.78 
   <$25,000/year 26 18.6 17 13.4   
   25,000-50,000/year 31 22.1 33 26.0   
   50,000-100,000/year 46 32.9 41 32.3   
   >100,000/year 30 21.4 28 22.1   
   Missing 7 5.0 8 6.3   
Educational Level      0.55 
   High School or less 48 34.3 39 30.7   
   College 48 34.3 52 40.9   
   Post-graduate 44 31.4 36 28.4   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
 
0.25 
   None 94 67.1 95 74.8   
   One or more 45 32.1 32 25.2   
   Missing 1 0.7 0 0.0   
Alcohol Consumption     0.20 
   None 30 21.4 19 15.0   
   Rare 85 60.7 73 57.5   
   >1 Drink/day 23 16.4 33 26.0   
   Missing 2 1.4 2 1.6   
Smoking History     0.90 
   Current Smoker 7 5.0 7 5.5   
   Past Smoker 68 48.6 67 52.8   
   Never Smoked 63 45.0 51 40.2   
   Missing 2 1.4 2 1.6   
Stage of cancer     0.56 
   Stage I 64 45.7 62 48.8   
   Stage II 63 45.0 52 40.9   
   Stage III 13 9.3 11 8.7   
   Missing 0 0.0 2 1.6   
Years Since Diagnosis     0.93 
   <5 years 53 37.9 46 36.2   
   5-10 years 66 47.1 60 47.2   
   >10 years 20 14.3 21 16.5   
   Missing 1 0.7 0 0.0   
Lymph Node Involvement     0.80 
    No 95 67.9 82 64.6   
    Yes 42 30.0 41 32.3   
    Missing 3 2.1 4 3.2   
Surgical Treatment     0.90 
    Lumpectomy 91 65.0 81 63.8   
    Mastectomy 49 35.0 46 36.2   
Chemotherapy     0.12 
    No 50 35.7 58 45.7   
    Yes 89 63.6 69 54.3   
    Missing 1 0.7 0 0.0   
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Hormonal Treatment     0.69 
    No 29 20.7 23 18.1   
    Yes 110 78.6 102 80.3   
    Missing 1 0.7 2 1.6   
Radiation Treatment     0.58 
   Negative 38 27.1 30 23.6   
   Positive 96 68.6 91 71.7   
   Missing 6 4.3 6 4.7   
ER Status     0.82 
   Negative 26 18.6 22 17.3   
   Positive 110 78.6 103 81.1   
   Missing 4 2.9 2 1.6   
PR Status     0.81 
   Negative 38 27.1 30 23.6   
   Positive 96 68.6 91 71.7   
   Missing 6 4.3 6 4.7   
Local Perceived Recurrence Risk     0.00 
   0-10% 54 38.6 73 57.5   
 10-30% 49 35.0 37 29.1   
  >30% 37 26.4 17 13.4   
Distant Perceived Recurrence Risk 0.12 
   0-10% 42 30.0 47 37.0   
 10-30% 48 34.3 49 38.6   
  >30% 50 35.7 31 24.4   
Adjuvant! Online Risk Score     0.32 
   0-10% 43 30.7 52 40.9   
 10-30% 81 57.9 61 48.0   
  >30% 14 10.0 13 10.2   
  Missing 2 1.4 1 0.8   
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 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN SMOKING: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in 
Smoking 
No Change in 
Smoking 
P-Value 
              Mean SD Mean SD   
 Age (years) 57.1 7.7 60.0 9.8 0.10 
  N % N %   
Race     0.01 
    Non-White 6 18.8 12 5.1   
    White 26 81.3 223 94.9   
Socioeconomic status     0.11 
   <$25,000/year 10 31.3 33 14.0   
   25,000-50,000/year 4 12.5 60 25.5   
   50,000-100,000/year 9 28.1 78 33.2   
   >100,000/year 8 25.0 50 21.3   
   Missing 1 3.1 14 6.0   
Educational Level      0.61 
   High School or less 13 40.6 74 31.5   
   College 11 34.4 89 37.9   
   Post-graduate 8 25.0 72 30.6   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  
0.48 
   None 25 78.1 164 69.8   
   One or more 7 21.9 70 29.8   
   Missing 0 0.0 1 0.4   
Alcohol Consumption     0.27 
   None 3 9.4 46 19.6   
   Rare 19 59.4 139 59.2   
   >1 Drink/day 9 28.1 47 20.0   
   Missing 1 3.1 3 1.3   
Smoking History     0.00 
   Current Smoker 10 31.3 4 1.7   
   Past Smoker 22 68.8 113 48.1   
   Never Smoked 0 0.0 114 48.5   
   Missing 0 0.0 4 1.7   
Stage of cancer     0.07 
   Stage I 9 28.1 117 49.8   
   Stage II 18 56.3 97 41.3   
   Stage III 5 15.6 19 8.1   
   Missing 0 0.0 2 0.9   
Years Since Diagnosis     0.46 
   <5 years 9 28.1 90 38.3   
   5-10 years 16 50.0 110 46.8   
   >10 years 7 21.9 34 14.5   
   Missing 0 0.0 1 0.4   
Lymph Node Involvement     0.02 
    No 15 46.9 162 68.9   
    Yes 15 46.9 68 28.9   
    Missing 2 6.3 5 2.1   
Surgical Treatment     0.70 
    Lumpectomy 22 68.8 150 63.8   
    Mastectomy 10 31.3 85 36.2   
Chemotherapy     0.17 
    No 8 25.0 100 42.6   
    Yes 24 75.0 134 57.0   
    Missing 0 0.0 1 0.4   
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Hormonal Treatment     0.76 
    No 5 15.6 47 20.0   
    Yes 27 84.8 185 78.7   
    Missing 0 0.0 3 1.3   
Radiation Treatment     1.00 
   No 7 21.9 50 21.3   
   Yes 25 78.1 183 77.9   
   Missing 0 0.0 2 0.9   
ER Status     0.83 
   Negative 5 15.6 43 18.3   
   Positive 26 81.3 187 79.6   
   Missing 1 3.1 5 2.1   
PR Status     0.57 
   Negative 6 18.8 62 26.4   
   Positive 24 75.0 163 69.4   
   Missing 2 6.3 10 4.3   
Local Perceived Recurrence Risk     0.68 
   0-10% 13 40.6 114 48.5   
 10-30% 12 37.5 74 31.5   
  >30% 7 21.9 47 20.0   
Distant Perceived Recurrence Risk 0.58 
   0-10% 8 25.0 81 34.5   
 10-30% 13 40.6 84 35.7   
  >30% 11 34.4 70 29.8   
Adjuvant! Online Risk Score     0.51 
   0-10% 8 25.0 87 37.0   
 10-30% 21 65.6 121 51.5   
  >30% 3 9.4 24 10.2   
  Missing 0 0.0 3 1.3   
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 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN SUN EXPOSURE: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in Sun 
Exposure 
No Change in 
Sun Exposure 
P-Value 
              Mean SD Mean SD   
Age (years) 60.3 9.8 59.2 9.4 0.34 
  N % N %   
Race     0.81 
    Non-White 7 6.1 11 7.2   
    White 108 93.9 141 92.8   
Socioeconomic status     0.57 
   <$25,000/year 23 20.0 20 13.2   
   25,000-50,000/year 24 20.9 40 26.3   
   50,000-100,000/year 36 31.3 51 33.6   
   >100,000/year 26 22.6 32 21.1   
   Missing 6 5.2 9 5.9   
Educational Level      0.10 
   High School or less 45 39.1 42 27.6   
   College 36 31.3 64 42.1   
   Post-graduate 34 29.6 46 30.3   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
   
0.04 
   None 74 64.4 115 75.7   
   One or more 41 35.7 36 23.7   
   Missing 0 0.0 1 0.7   
Alcohol Consumption     0.23 
   None 24 20.9 25 16.5   
   Rare 69 60.0 89 58.6   
   >1 Drink/day 19 16.5 37 24.3   
   Missing 3 2.6 1 0.7   
Smoking History     0.39 
   Current Smoker 6 5.2 8 5.3   
   Past Smoker 57 49.6 78 51.3   
   Never Smoked 52 45.2 62 40.8   
   Missing 0 0.0 4 2.6   
Stage of cancer     0.00 
   Stage I 55 47.8 71 46.7   
   Stage II 41 35.7 74 48.7   
   Stage III 18 15.7 6 4.0   
   Missing 1 0.9 1 0.7   
Years Since Diagnosis     0.27 
   <5 years 43 37.4 56 36.8   
   5-10 years 59 51.3 67 44.1   
   >10 years 13 11.3 28 18.4   
   Missing 0 0.0 1 0.7   
Lymph Node Involvement     0.76 
    No 76 66.1 101 66.5   
    Yes 35 30.4 48 31.6   
    Missing 4 3.5 3 2.0   
Surgical Treatment     0.52 
    Lumpectomy 77 67.0 95 62.5   
    Mastectomy 38 33.0 57 37.5   
Chemotherapy     0.05 
    No 54 47.0 54 35.5   
    Yes 60 52.2 98 64.5   
    Missing 1 0.9 0 0.0   
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Hormonal Treatment     0.61 
    No 24 20.9 28 18.4   
    Yes 89 77.4 123 80.9   
    Missing 2 1.7 1 0.7   
Radiation Treatment     0.04 
   No 17 14.8 40 26.3   
   Yes 97 84.4 111 73.0   
   Missing 1 0.9 1 0.7   
ER Status     0.82 
   Negative 22 19.1 26 17.1   
   Positive 90 78.3 123 80.9   
   Missing 3 2.6 3 2.0   
PR Status     0.18 
   Negative 34 29.6 34 22.4   
   Positive 74 64.4 113 74.3   
   Missing 7 6.1 5 3.3   
Local Perceived Recurrence Risk     0.12 
   0-10% 50 43.5 77 50.7   
 10-30% 35 30.4 51 33.6   
  >30% 30 26.1 24 15.8   
Distant Perceived Recurrence Risk 0.03 
   0-10% 29 25.2 60 39.5   
 10-30% 43 37.4 54 35.5   
  >30% 43 37.4 38 25.0   
Adjuvant! Online Risk Score     0.81 
   0-10% 40 34.8 55 36.2   
 10-30% 60 52.2 82 54.0   
  >30% 13 11.3 14 9.2   
  Missing 2 1.7 1 0.7   
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 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN SUPPLEMENT 
USE: BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT 
PAGE) 
                                                         Change in 
Supplement Use 
No Change in 
Supplement Use 
P-Value 
              Mean SD Mean SD   
Age (years) 59.7 9.1 59.6 10.1 0.99 
  
N % N %   
Race     1.00 
    Non-White 9 6.6 9 6.9   
    White 128 93.4 121 93.1   
Socioeconomic status     0.50 
   <$25,000/year 22 16.1 21 16.2   
   25,000-50,000/year 27 19.7 37 28.5   
   50,000-100,000/year 46 33.6 41 31.5   
   >100,000/year 33 24.1 25 19.2   
   Missing 9 6.6 6 4.6   
Educational Level      0.08 
   High School or less 36 26.3 51 39.2   
   College 57 41.6 43 33.1   
   Post-graduate 44 32.1 36 27.7   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
   
0.95 
   None 96 70.1 93 71.5   
   One or more 40 29.2 37 28.5   
   Missing 1 0.7 0 0.0   
Alcohol Consumption     0.96 
   None 24 17.5 25 19.2   
   Rare 83 60.6 75 57.7   
   >1 Drink/day 28 20.4 28 21.5   
   Missing 2 1.5 2 1.5   
Smoking History     0.43 
   Current Smoker 9 6.6 5 3.9   
   Past Smoker 64 46.7 71 54.6   
   Never Smoked 61 44.5 53 40.8   
   Missing 3 2.2 1 0.8   
Stage of cancer     0.69 
   Stage I 60 43.8 66 50.8   
   Stage II 64 46.7 51 39.2   
   Stage III 12 8.8 12 9.2   
   Missing 1 0.7 1 0.8   
Years Since Diagnosis     0.00 
   <5 years 67 48.9 32 24.6 
  
   5-10 years 57 41.6 69 53.1   
   >10 years 12 8.8 29 22.3   
   Missing 1 0.7 0 0.0   
Lymph Node Involvement     0.47 
    No 87 63.5 90 69.2   
    Yes 47 34.3 36 27.7   
    Missing 3 2.2 4 3.1   
Surgical Treatment     0.70 
    Lumpectomy 90 65.7 82 63.1   
    Mastectomy 47 34.3 48 36.9   
Chemotherapy     0.45 
    No 52 38.0 56 43.1   
    Yes 84 61.3 74 56.9   
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    Missing 1 0.7 0 0.0   
Hormonal Treatment     0.17 
    No 21 15.3 31 23.9   
    Yes 114 83.2 98 75.4   
    Missing 2 1.5 1 0.8   
Radiation Treatment     0.25 
   No 26 19.0 31 23.9   
   Yes 109 79.6 99 76.2   
   Missing 2 1.5 0 0.0   
ER Status     0.76 
   Negative 23 16.8 25 19.2   
   Positive 110 80.3 103 79.2   
   Missing 4 2.9 2 1.5   
PR Status      0.59 
   Negative 34 24.8 34 26.2   
   Positive 95 69.3 92 70.8   
   Missing 8 5.8 4 3.1   
Local Perceived Recurrence Risk     0.60 
   0-10% 61 44.5 66 50.8   
 10-30% 47 34.3 39 30.0   
  >30% 29 21.2 25 19.2   
Distant Perceived Recurrence Risk 0.44 
   0-10% 42 30.7 47 36.2   
 10-30% 49 35.8 48 36.9   
  >30% 46 33.6 35 26.9   
Adjuvant! Online Risk Score     0.95 
   0-10% 50 36.5 45 34.6   
 10-30% 72 52.6 70 53.9   
  >30% 14 10.2 13 10.0   
  Missing 1 0.7 2 1.5   
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 DISTRIBUTION OF COVARIATES ACCORDING TO CHANGE IN WEIGHT: 
BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT PAGE) 
                                                         Change in 
Weight 
No Change in 
Weight 
P-Value 
              Mean SD Mean SD   
Age (years) 58.9 9.4 60.8 9.8 0.10 
  
N % N %   
Race     0.62 
    Non-White 12 7.6 6 5.5   
    White 146 92.4 103 94.5   
Socioeconomic status     0.69 
   <$25,000/year 28 17.7 15 13.8   
   25,000-50,000/year 37 23.4 27 24.8   
   50,000-100,000/year 49 31.0 38 34.9   
   >100,000/year 33 20.9 25 22.9   
   Missing 11 7.0 4 3.7   
Educational Level      0.30 
   High School or less 47 29.8 40 36.7   
   College 67 40.5 36 33.0   
   Post-graduate 47 29.8 33 30.3   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  
0.70 
   None 109 69.0 80 73.4   
   One or more 48 30.4 29 26.6   
   Missing 1 0.6 0 0.0   
Alcohol Consumption     0.09 
   None 35 22.2 14 12.8   
   Rare 84 53.2 74 67.9   
   >1 Drink/day 36 22.8 20 18.4   
   Missing 3 1.9 1 0.9   
Smoking History     0.93 
   Current Smoker 8 5.1 6 5.5   
   Past Smoker 82 51.9 53 48.6   
   Never Smoked 66 41.8 48 44.0   
   Missing 2 1.3 2 1.8   
Stage of cancer     0.79 
   Stage I 76 48.1 50 45.9   
   Stage II 65 41.1 50 45.9   
   Stage III 16 10.1 8 7.3   
   Missing 1 0.6 1 0.9   
Years Since Diagnosis     0.13 
   <5 years 61 38.6 38 34.9   
   5-10 years 78 49.4 48 44.0   
   >10 years 18 11.4 23 21.1   
   Missing 1 0.6 0 0.0   
Lymph Node Involvement     0.21 
    No 104 65.8 73 67.0   
    Yes 52 32.9 31 28.4   
    Missing 2 1.3 5 4.6   
Surgical Treatment     0.24 
    Lumpectomy 97 61.4 75 68.8   
    Mastectomy 61 38.6 34 31.2   
Chemotherapy     0.04 
    No 55 34.8 53 48.6   
    Yes 102 64.6 56 51.4   
    Missing 1 0.6 0 0.0   
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Hormonal Treatment     0.89 
    No 32 20.3 20 18.4   
    Yes 124 78.5 88 80.7   
    Missing 2 1.3 1 0.9   
Radiation Treatment     0.69 
   No 33 20.9 24 22.0   
   Yes 123 77.9 85 78.0   
   Missing 2 1.3 0 0.0   
ER Status     0.68 
   Negative 31 19.6 17 15.6   
   Positive 123 77.9 90 82.6   
   Missing 4 2.5 2 1.8   
PR Status     0.51 
   Negative 44 27.9 24 22.0   
   Positive 108 68.4 79 72.5   
   Missing 6 3.8 6 5.5   
Local Perceived Recurrence Risk     0.40 
   0-10% 71 44.9 56 51.4   
 10-30% 51 32.3 35 32.1   
  >30% 36 22.8 18 16.5   
Distant Perceived Recurrence Risk 0.07 
   0-10% 46 29.1 43 39.5   
 10-30% 56 35.4 41 37.6   
  >30% 56 35.4 25 22.9   
Adjuvant! Online Risk Score     0.92 
   0-10% 55 34.8 40 36.7   
 10-30% 86 54.4 56 51.4   
  >30% 15 9.5 12 11.0   
  Missing 2 1.3 1 0.9   
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DISTRIBUTION OF COVARIATES ACCORDING TO DIRECTION OF BEHAVIOR 
CHANGE: BREAST CANCER SURVIVORSHIP STUDY, 2008 (CONTINUED ON NEXT 
PAGE) 
                                                         No Behavior 
Change 
Any Positive 
Behavior 
Change 
Any Negative 
Behavior 
Change 
P-Value 
              Mean SD Mean SD Mean SD   
   Age (years) 55.1 9.7 59.6 9.2 58.3 8.9 0.01 
  
N % N % N %   
Race         0.38 
    Non-White 2 11.8 11 5.3 8 7.0   
    White 15 88.2 195 94.7 106 93.0   
Socioeconomic status         0.92 
   <$25,000/year 2 11.8 30 14.6 19 16.7   
   25,000-50,000/year 4 23.5 50 24.3 27 23.7   
   50,000-100,000/year 7 41.2 72 35.0 33 29.0   
   >100,000/year 4 23.5 44 21.4 26 22.8   
   Missing 0 0.0 10 4.9 9 7.9   
Educational Level          0.97 
   High School or less 4 23.5 66 32.0 37 32.5   
   College 7 41.2 76 36.9 43 37.7   
   Post-graduate 6 35.3 64 31.1 34 29.8   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
      
0.13 
   None 16 94.1 141 68.5 76 66.7   
   One or more 1 5.9 64 31.1 37 32.5   
   Missing 0 0.0 1 0.5 1 0.9   
Alcohol Consumption         0.97 
   None 2 11.8 41 19.9 20 17.5   
   Rare 11 64.7 120 58.3 66 57.9   
   >1 Drink/day 4 23.5 42 20.4 26 22.8   
   Missing 0 0.0 3 1.5 2 1.8   
Smoking History         0.88 
   Current Smoker 1 5.9 10 4.9 6 5.3   
   Past Smoker 11 64.7 107 51.9 58 50.9   
   Never Smoked 5 29.4 87 42.2 48 42.1   
   Missing 0 0.0 2 1.0 2 1.8   
Stage of cancer         0.97 
   Stage I 8 47.1 95 46.1 53 46.5   
   Stage II 8 47.1 87 42.2 45 39.5   
   Stage III 1 5.9 22 10.7 15 13.2   
   Missing 0 0.0 2 1.0 1 0.9   
Years Since Diagnosis         0.19 
   <5 years 2 11.8 79 38.4 44 38.6   
   5-10 years 10 58.8 95 46.1 56 49.1   
   >10 years 5 29.4 31 15.1 14 12.3   
   Missing 0 0.0 1 0.5 0 0.0   
Lymph Node Involvement         0.88 
    No 13 76.5 133 64.6 74 64.9   
    Yes 4 23.5 67 32.5 38 33.3   
    Missing 0 0.0 6 2.9 2 1.8   
Surgical Treatment         0.94 
    Lumpectomy 10 58.8 129 62.6 72 63.2   
    Mastectomy 7 41.2 77 37.4 42 36.8   
Chemotherapy         0.40 
    No 6 35.3 85 41.3 37 32.5   
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    Yes 11 64.7 120 58.3 77 67.5   
    Missing 0 0.0 1 0.5 0 0.0   
Hormonal Treatment         0.21 
    No 7 41.2 37 18.0 25 21.9   
    Yes 10 58.8 166 80.6 88 77.2   
    Missing 0 0.0 3 1.5 1 0.9   
Radiation Treatment         0.56 
   No 5 29.5 45 21.8 20 17.5   
   Yes 12 70.6 160 77.7 93 81.6   
   Missing 0 0.0 1 0.5 1 0.9   
ER Status         0.38 
   Negative 6 35.3 35 17.0 25 21.9   
   Positive 11 64.7 165 80.1 86 75.4   
   Missing 0 0.0 6 2.9 3 2.6   
PR Status         0.68 
   Negative 6 35.3 52 25.2 36 31.6   
   Positive 11 64.7 143 69.4 73 64.0   
   Missing 0 0.0 11 5.3 5 4.4   
Adjuvant! Online Risk Score         0.74 
   0-10% 3 17.7 76 36.9 40 35.1   
 10-30% 12 70.6 107 51.9 60 52.6   
  >30% 2 11.8 20 9.7 13 11.4   
  Missing 0 0.0 3 1.5 1 0.9   
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APPENDIX I 
 
DISTRIBUTION OF COVARIATES ACCORDING TO PERCEIVED LOCAL 
RECURRENCE RISK: BREAST CANCER SURVIVORSHIP STUDY, 2008 
(CONTINUED ON NEXT PAGE) 
                                                         0-10% 10-30% >30% P-Value 
              Mean SD Mean SD Mean SD   
Age (years) 60.0 10.2 59.5 9.1 59.2 8.9 0.98 
  
N % N % N %   
Race            0.63 
    Non-White 9 7.1 7 8.1 2 3.7   
    White 118 92.9 79 91.9 52 96.3   
Socioeconomic status            0.57 
   <$25,000/year 23 18.1 11 12.8 9 16.7   
   25,000-50,000/year 30 23.6 16 18.6 18 33.3   
   50,000-100,000/year 42 33.1 31 36.1 14 25.9   
   >100,000/year 24 18.9 23 26.7 11 20.4   
   Missing 8 6.3 5 5.8 2 3.7   
Educational Level             0.04 
   High School or less 39 30.7 22 25.6 26 48.2   
   College 54 42.5 31 36.1 15 27.8   
   Post-graduate 34 26.8 33 38.4 13 24.1   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
        
0.25 
   None 91 71.7 65 75.6 33 61.1   
   One or more 35 27.6 21 24.4 21 38.9   
   Missing 1 0.8 0 0.0 0 0.0   
Alcohol Consumption            0.39 
   None 28 22.1 10 11.6 11 20.4   
   Rare 73 57.5 52 60.5 33 61.1   
   >1 Drink/day 25 19.7 22 25.6 9 16.7   
   Missing 1 0.8 2 2.3 1 1.9   
Smoking History            0.61 
   Current Smoker 8 6.3 5 5.8 1 1.9   
   Past Smoker 63 49.6 47 54.7 25 46.3   
   Never Smoked 54 42.5 32 37.2 28 51.9   
   Missing 2 1.6 2 2.3 0 0.0   
Stage of cancer            0.48 
   Stage I 66 52.0 39 45.4 21 38.9   
   Stage II 51 40.2 37 43.0 27 50.0   
   Stage III 9 7.1 10 11.6 5 9.3   
   Missing 1 0.8 0 0.0 1 1.9   
Years Since Diagnosis            0.07 
   <5 years 46 36.2 31 36.1 22 40.7   
   5-10 years 58 45.7 48 55.8 20 37.0   
   >10 years 23 18.1 7 8.1 11 20.4   
   Missing 0 0.0 0 0.0 1 1.9   
Lymph Node Involvement            0.07 
    No 93 73.2 54 62.8 30 55.6   
    Yes 31 24.4 31 36.1 21 38.9   
    Missing 3 2.4 1 1.2 3 5.6   
Surgical Treatment            0.08 
    Lumpectomy 74 58.3 63 73.3 35 64.8   
    Mastectomy 53 41.7 23 26.7 19 35.2   
Chemotherapy            0.20 
    No 56 44.1 35 40.7 17 31.5   
    Yes 71 55.9 51 59.3 36 66.7   
    Missing 0 0.0 0 0.0 1 1.9   
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Hormonal Treatment            0.03 
    No 29 22.8 9 10.5 14 25.9   
    Yes 95 74.8 77 89.5 40 74.1   
    Missing 3 2.4 0 0.0 0 0.0   
Radiation Treatment            0.00 
   No 40 31.5 8 9.3 9 16.7   
   Yes 86 67.7 78 90.7 44 81.5   
   Missing 1 0.8 0 0.0 1 1.9   
ER Status            0.15 
   Negative 27 21.3 9 10.5 12 22.2   
   Positive 96 75.6 76 88.4 41 75.9   
   Missing 4 3.2 1 1.2 1 1.9   
PR Status             0.17 
   Negative 33 26.0 18 20.9 17 31.5   
   Positive 89 70.1 66 76.7 32 59.3   
   Missing 5 3.9 2 2.3 5 9.3   
Adjuvant! Online Risk Score            0.23 
   0-10% 50 39.4 32 37.2 13 24.1   
 10-30% 63 49.6 47 54.7 32 59.3   
  >30% 13 10.2 7 8.1 7 13.0   
  Missing 1 0.8 0 0.0 2 3.7   
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DISTRIBUTION OF COVARIATES ACCORDING TO PERCEIVED DISTANT 
RECURRENCE RISK: BREAST CANCER SURVIVORSHIP STUDY, 2008 
(CONTINUED ON NEXT PAGE) 
                                                         0-10% 10-30% >30% P-Value 
              Mean SD Mean SD Mean SD   
   Age (years) 61.0 10.1 58.7 9.3 59.3 9.3 0.99 
  
N % N % N %   
Race       0.62 
    Non-White 8 9.0 5 5.2 5 6.2   
    White 81 91.0 92 94.9 76 93.8   
Socioeconomic status       0.82 
   <$25,000/year 14 15.7 16 16.5 13 16.1   
   25,000-50,000/year 23 25.8 19 19.6 22 27.2   
   50,000-100,000/year 30 33.7 36 37.1 21 25.9   
   >100,000/year 17 19.1 22 22.7 19 23.5   
   Missing 5 5.6 4 4.1 6 7.4   
Educational Level        0.25 
   High School or less 27 30.3 26 26.8 34 42.0   
   College 33 37.1 42 43.3 25 30.9   
   Post-graduate 29 32.6 29 29.9 22 27.2   
Family History of Breast Cancer                                                                                              
(1st deg relative) 
  
0.06 
   None 60 67.4 77 79.4 52 64.2   
   One or more 28 31.5 20 20.6 29 35.8   
   Missing 1 1.1 0 0.0 0 0.0   
Alcohol Consumption       0.87 
   None 19 21.4 15 15.5 15 18.5   
   Rare 51 57.3 62 63.9 45 55.6   
   >1 Drink/day 18 20.2 19 19.6 19 23.5   
   Missing 1 1.1 1 1.0 2 2.5   
Smoking History       0.85 
   Current Smoker 6 6.7 4 4.1 4 4.9   
   Past Smoker 40 44.9 54 55.7 41 50.6   
   Never Smoked 41 46.1 38 39.2 35 43.2   
   Missing 2 2.3 1 1.0 1 1.2   
Stage of cancer       0.20 
   Stage I 48 53.9 44 45.4 34 42.0   
   Stage II 34 38.2 45 46.4 36 44.4   
   Stage III 5 5.6 8 8.3 11 13.6   
   Missing 2 2.3 0 0.0 0 0.0   
Years Since Diagnosis       0.13 
   <5 years 26 29.2 38 39.2 35 43.2   
   5-10 years 43 48.3 48 49.5 35 43.2   
   >10 years 20 22.5 11 11.3 10 12.4   
   Missing 0 0.0 0 0.0 1 1.2   
Lymph Node Involvement       0.32 
    No 65 73.0 64 66.0 48 59.3   
    Yes 21 23.6 31 32.0 31 38.3   
    Missing 3 3.4 2 2.1 2 2.5   
Surgical Treatment       0.15 
    Lumpectomy 61 68.5 66 68.0 45 55.6   
    Mastectomy 28 31.5 31 32.0 36 44.4   
Chemotherapy       0.06 
    No 45 50.6 36 37.1 27 33.3   
    Yes 44 49.4 61 62.9 53 65.4   
     Missing 0 0.0 0 0.0 1 1.2   
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Hormonal Treatment       0.51 
    No 18 20.2 16 16.5 18 22.2   
    Yes 69 77.5 81 83.5 62 76.5   
    Missing 2 2.3 0 0.0 1 1.2   
Radiation Treatment       0.74 
   No 21 23.6 18 18.6 18 22.2   
   Yes 67 75.3 79 81.4 62 76.5   
   Missing 1 1.2 0 0.0 1 1.2   
ER Status        0.57 
   Negative 18 20.2 14 14.4 16 19.8   
   Positive 69 77.5 82 84.5 62 76.5   
   Missing 2 2.3 1 1.0 3 3.7   
PR Status        0.16 
   Negative 23 25.8 19 19.6 26 32.1   
   Positive 63 70.8 75 77.3 49 60.5   
   Missing 3 3.4 3 3.1 6 7.4   
Adjuvant! Online Risk Score       0.72 
   0-10% 35 39.3 35 36.1 25 30.9   
 10-30% 45 50.6 53 54.6 44 54.3   
  >30% 8 9.0 9 9.3 10 12.4   
  Missing 1 1.1 0 0.0 2 2.5   
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